This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-029547-9ei1ram3 | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Characteristics of ocular findings of patients with coronavirus disease 2019( COVID-19 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-021453-vf8xbaug | Dirofilaria immitis: Do filarial cyclooxygenase products depress endothelium- dependent relaxation in the in vitro rat aorta? |
| cord-273973-3uxg97tu | Nosocomial bloodstream infections in a nationwide study: comparison between solid organ transplant patients and the general population Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome Bacteremia and septic shock after solidorgan transplantation Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? |
| cord-022520-ebj51v9o | The characterization and pathological significance of gastric CampyIobacter- like organisms in the ferret: a model of chronic gastritis? |
| cord-282202-q2q4vies | A fiasco in the making? |
| cord-258029-gyvg7ffa | A review of the safety of favipiravir- a potential treatment in the COVID-19 pandemic? |
| cord-023367-ujflw19b | in goats farmed under resource- poor conditions in South Africa using an eye colour chart developed for sheep Validation of the FAMA- CHA eye color chart for detecting clinical anemia in sheep and goats on farms in the southern United States Validation of the FAMACHA © eye colour chart using sensitivity/ specificity analysis on two South African sheep farms Is the FAMACHA chart suitable for every breed? |
| cord-022034-o27mh4wz | The Sverdlovsk anthrax outbreak of 1979 Death at Sverdlovsk: What have we learned? |
| cord-031188-btrc3k4c | Infect Dis Overview, challenges and future prospects of drug information services in Nepal: a reflective commentary A study of potential drug- drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal Can drug utilization help in promoting the more rational use of medicine? |
| cord-031188-btrc3k4c | The changing face of pharmacy practice and the need for a new model of pharmacy education Individual capacity- building approaches in a global pharmaceutical systems strengthening program: a selected review Capacity building in pharmacy education in resource- poor settings: an ethnographic case study of Malawi PharmD or needs based education: which comes first? |
| cord-277528-t0tglg0a | The impact of COVID-19 454 epidemic declaration on psychological consequences: A study on active Weibo users Guidance on participation 457 in clinical education experiences in physical therapy education Considerations for COVID-19 462 Preparedness and Response in U.S. Schools of Nursing Mediated learning in the workplace: student perspectives on 467 knowledge resources Is there a role for simulation based education within conventional 470 diagnostic radiography? |
| cord-282298-8tcw3cll | How to do it? |
| cord-272727-a5ngjuyz | How will country- based 680 mitigation measures influence the course of the covid-19 epidemic? |
| cord-283545-vu8lt3w6 | Adenovirus pneumonia in guineapigs: an experimental reproduction of the disease Torulopsis pintolopesii-an opportunistic pathogen in guineapigs? |
| cord-308284-r546ypur | The question then arose: How many lives would have been saved if effective medical countermeasures had been made available sooner? |
| cord-258049-l55mx4lp | Pediatrics Hospital readmission: quality indicator or statistical inevitability? |
| cord-258049-l55mx4lp | We used the question:"How long ago did the following symptoms[ eg, difficulty breathing] begin[ for the] current illness?" |
| cord-296692-t5p09le8 | What next? |
| cord-280431-tuzdng4h | In contrast, the payers for clinical education( investment) are very far from the payers for health care( insurance?) |
| cord-267608-0odu8lus | imatinib[ 6, 40] Assessing the gold standard-- lessons from the history of RCTs Cancer clinical trials: the rear- view mirror and the crystal ball Adaptive designs for clinical trials chemisimilars and biosimilars: is clinical testing fit for purpose? |
| cord-267608-0odu8lus | retrospective cohort study Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? |
| cord-262843-i0cy7467 | background Do patients with sore throat benefit from penicillin? |
| cord-262843-i0cy7467 | pharyngitis Diagnosis of strep throat in adults: are clinical criteria really good enough? |
| cord-283779-mudwcypl | Compared to Standard of Care Treatment Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Covid-19: trials of four potential treatments to generate"robust data"of what works Covid-19: what treatments are being investigated? |
| cord-283779-mudwcypl | How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? |
| cord-312677-rwznqiib | COVID-19 pneumonia: an increased risk for candidemia? |
| cord-255140-3dwqqgv1 | An overview on the use of a viral pathogen as a bioterrorism agent: why smallpox? |
| cord-255140-3dwqqgv1 | The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? |
| cord-017331-ru7mvfc0 | 2009 H1N1 and swine H1N1 and H3N2 triple reassortant influenza viruses Bird life in the National Park A review of West Nile and Usutu virus co- circulation in Europe: how much do transmission cycles overlap? |
| cord-017331-ru7mvfc0 | A study of the hemorrhagic septicemia Pasteurellae Campylobacter jejuni and Proventricular Dilatation Disease in parrots: there may be a correlation? |
| cord-017331-ru7mvfc0 | Les blastomycètes pathogènes Does the roosting behavior of birds affect transmission dynamics of West Nile virus? |
| cord-262784-r9gq2oan | Also, are there any special characteristics of patients who can not be released from quarantine for a long period? |
| cord-262784-r9gq2oan | As a region outside Hubei province, what are the similarities and differences between the characteristics of the cases diagnosed here and those diagnosed in Hubei province and even other countries and regions? |
| cord-308421-22rcptor | A position paper of the ARCAD group Thoracic oncology clinical trial eligibility criteria and requirements continue to increase in number and complexity Patients with advanced nonsmall cell lung cancer: are research biopsies a barrier to participation in clinical trials? |
| cord-316029-z708c3ex | Does beta- lactam pharmacokinetic variability in critically ill patients justify therapeutic drug monitoring? |
| cord-310027-846vp7ii | : what are they and which is better? |
| cord-310027-846vp7ii | Is it Really Needed? |
| cord-319805-b6ypt5d0 | oxford centre for evidence- based medicine What to add to nothing? |
| cord-309080-1r8t8yxv | : What's Next? |
| cord-309080-1r8t8yxv | Is Medical Education Ready for Generation Z? |
| cord-340656-ltd6ueoi | SARS- CoV-2 infection in 86 healthcare workers in two Dutch Clinical characteristics of 50404 patients with 2019-nCoV infection Real- time tracking of self- reported symptoms to predict potential COVID-19 A framework for identifying regional outbreak and spread of COVID-19 from one- minute population- wide surveys Can Meta- analysis Be Salvaged? |
| cord-298899-lkrmg5qr | , it seems that Fuyang patients are not infectious What is Kawasaki disease and its possible link with COVID-19 in children? |
| cord-298899-lkrmg5qr | Novel coronavirus pneumonia prevention and control program Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-034340-3ksfpaf7 | Before making a definitive diagnosis of HLH patients were treated for PUO, sepsis? |
| cord-034340-3ksfpaf7 | None declared AB041 Paediatric extra- pulmonary large vessel arteritis, a forme fruste of pediatric Behcet's disease? |
| cord-333340-ekok0mp5 | : what is the optimal approach for detection of Clostridium difficile infection? |
| cord-021494-9glqvzfx | ( diagnosis),"how it going to behave?" |
| cord-021494-9glqvzfx | ( prognosis), and"how do I treat it?" |
| cord-021494-9glqvzfx | Pathologists collect the data needed to answer patients'and clinicians'questions, simply phrased as"what is it?" |
| cord-007321-7gi6xrci | A placebo- controlled, double- blind trial of erythromycin in adults with acute bronchitis Role of infection in chronic bronchitis Antibiotictherapy in exacerbations of chronic obstructive pulmonary disease Community- acquired pneumonia and acutebronchitis Prospective study of the aetiology and outcome of pneumonia in the community Howcommonis legionnaire's disease? |
| cord-007321-7gi6xrci | Does penicillin make Johnny's strep throat better? |
| cord-007321-7gi6xrci | Information about concentrations? |
| cord-331557-8axi74nn | key: cord-331557- 8axi74nn authors: Raoult, Didier; Fournier, Pierre Edouard; Drancourt, Michel title: What does the future hold for clinical microbiology? |
| cord-332078-vl309ss7 | Immediate psychological responses and associated factors during the initial stage of the 2019 Coronavirus Disease( COVID-19) epidemic among the general population in China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia Low- dose corticosteroid therapy does not delay viral clearance in patients with COVID-19 Agents to reduce cytokine storm COVID-19: consider cytokine storm syndromes and immunosuppression Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-333285-0s6dnm9i | We Needed For Using Digital Technology To Increase Access For Rural Participants? |
| cord-354216-4khdcjed | Will the Quality of Research Remain the Same During the COVID-19 Pandemic? |
| cord-331268-kzy33hdb | : Relationship to a retrovirus? |
| cord-323940-ubazgvov | The trinity of COVID-19: immunity, inflammation and intervention The pathogenesis and treatment of the` Cytokine Storm'in COVID-19 The eye as the discrete but defensible portal of coronavirus infection Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-323940-ubazgvov | what to expect for COVID-19? |
| cord-299082-s8bm40vy | An example of reversible electrical storm Incessant monomorphic ventricular tachycardia during febrile illness in a patient with Brugada syndrome: fatal electrical storm Fhf2 gene deletion causes temperature- sensitive cardiac conduction failure Fever increases the risk for cardiac arrest in the Brugada syndrome Hyperthermia influences the effects of sodium channel blocking drugs in human- induced pluripotent stem cell- derived cardiomyocytes Controversies of renin- angiotensin system inhibition during the COVID-19 pandemic Antihypertensive treatment with ACEI/ ARB of patients with COVID-19 complicated by hypertension Angiotensin II and angiotensin 1- 7: which is their role in atrial fibrillation? |
| cord-299082-s8bm40vy | COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-253295-82ydczid | ( diagnosis),"how it going to behave?" |
| cord-253295-82ydczid | ( prognosis), and"how do I treat it?" |
| cord-253295-82ydczid | Pathologists collect the data needed to answer patients'and clinicians'questions, simply phrased as"what is it?" |
| cord-326331-g4o3forj | Society of NeuroInterventional Surgery recommendations for the care of emergent neurointerventional patients in the setting of COVID-19 Letter: considerations for performing emergent neurointerventional procedures in a COVID-19 environment Preserving access: a review of stroke thrombectomy during the COVID-19 pandemic How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-326331-g4o3forj | Virtually perfect? |
| cord-324388-onc441uw | : patient attitudes and perceptions Are patients comfortable consenting to clinical anesthesia research trials on the day of surgery? |
| cord-324388-onc441uw | what? |
| cord-003878-nmyyt51x | Does modern medicine still need autopsy? |
| cord-003878-nmyyt51x | How can it be expected that these future doctors may believe in the benefits of the autopsy and request it in their routine practice? |
| cord-003878-nmyyt51x | The impact of declining clinical autopsy: need for revised healthcare policy What does the future hold? |
| cord-003878-nmyyt51x | What does the future hold? |
| cord-276740-4wwo9tho | But is it? |
| cord-276740-4wwo9tho | Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? |
| cord-276740-4wwo9tho | The weirdest people in the world? |
| cord-352177-05sku8a8 | Patient distrust in pharmaceutical companies: an explanation for women under- representation in respiratory clinical trials? |
| cord-340028-6oicmeam | Can physical activity ameliorate immunosenescence and thereby reduce age- related multi- morbidity? |
| cord-340028-6oicmeam | Should We Treat Aging as a Disease? |
| cord-002626-jzwwses4 | : does it improve clinical outcome? |
| cord-002626-jzwwses4 | A randomized controlled trial Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective Cytomegalovirus in hematopoietic stem cell transplant recipients Cytomegalovirus quantification: where to next in optimising patient management? |
| cord-002626-jzwwses4 | Busulfan pharmacokinetic lab cross verification results Personalizing busulfanbased conditioning: considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee Liquid chromatography- tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals Immunoassays for testosterone in women: better than a guess? |
| cord-002626-jzwwses4 | The'70% claim': what is the evidence base? |
| cord-002626-jzwwses4 | hdsa.org Targets for future clinical trials in Huntington's disease: what's in the pipeline? |
| cord-353887-f4yd7guj | Intravenous immunoglobulin therapy: how does IgG modulate the immune system? |
| cord-353887-f4yd7guj | the Guangzhou experience Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia Decoding the enigma of antiviral crisis: does one target molecule regulate all? |
| cord-001687-paax8pqh | A contribution on causal osteogenesis Bone graft substitutes: What are the options? |
| cord-001687-paax8pqh | Can bone tissue engineering contribute to therapy concepts after resection of musculoskeletal sarcoma? |
| cord-001687-paax8pqh | The growth of tissue engineering Support for tissue engineering and regenerative medicine by the National Institutes of Health Scaffold engineering: a bridge to where? |
| cord-001687-paax8pqh | do we understand it? |
| cord-333581-icp0xwhx | ( COVID-19 Are gastrointestinal symptoms specific for COVID-19 infection? |
| cord-333581-icp0xwhx | Clinical characteristics of coronavirus disease 2019 in China Is SARS- CoV-2 also an enteric pathogen with potential fecal- oral transmission? |
| cord-333581-icp0xwhx | The association of low serum albumin level with severe COVID-19: a systematic review and meta- analysis Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-348244-1py0k53e | -what is it and what can it tell us? |
| cord-348244-1py0k53e | Transforming Clinical Research in the United States Randomized clinical trials- removing unnecessary obstacles The value of source data verification in a cancer clinical trial Risk- adapted monitoring is not inferior to extensive on- site monitoring: results of the ADAMON cluster- randomised study Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched- pair study A randomized evaluation of on- site monitoring nested in a multinational randomized trial Validation of a riskassessment scale and a risk- adapted monitoring plan for academic clinical research studies- the Pre- Optimon study Improving the quality of drug research or simply increasing its cost? |
| cord-349210-8t4a5qqo | COVID-19: a case for inhibiting IL-17? |
| cord-349210-8t4a5qqo | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-349210-8t4a5qqo | FDA Commissioner Says Agency Wants to Develop Master Protocol Trials to Test Multiple COVID-19 Drug and Vaccine Candidates at Once 79 Treatment for COVID-19 in High- Risk Adult Outpatients Clinical characteristics of coronavirus disease 2019 in China Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti- Inflammatory Therapy Pulmonary fibrosis secondary to COVID-19: a call to arms? |
| cord-336563-hwemigk7 | A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Medication patterns and disease progression among 165 patients with coronavirus disease 2019( COVID-19) in Wuhan, China: a single- centered, retrospective, observational study Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease SARS: systematic review of treatment effects Effective treatment of severe COVID-19 patients with Tocilizumab Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study ACTEMRA ®( tocilizumab) injection, for intravenous or subcutaneous use Interleukin-6 and cytochrome- P450, reason for concern? |
| cord-336563-hwemigk7 | Should ACE and ARB's for hypertension be stopped in patients infected with COVID19? |
| cord-336563-hwemigk7 | Should NSAIDS be stopped in patients infected with COVID-19? |
| cord-306351-ka6asw3m | ( COVID-19): A Review A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19 Arbidol combined with LPV/ r versus LPV/ r alone against Corona Virus Disease 2019: A retrospective cohort study Baricitinib for COVID-19: a suitable treatment? |
| cord-306351-ka6asw3m | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-306351-ka6asw3m | Hydroxychloroquine in Covid-19: Does the end justify the means? |
| cord-306351-ka6asw3m | Is Blocked by a Clinically Proven Protease Inhibitor Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-304479-uxp1kg86 | A Periodic Systematic Review and Meta- Analysis Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non- randomized clinical trial Is Hydroxychloroquine Safe During Pregnancy? |
| cord-304479-uxp1kg86 | A first step in understanding SARS pathogenesis Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS coronavirus Prosper, Inhibition of SARS- CoV-2 infections in engineered human tissues using clinical- grade soluble human Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-304479-uxp1kg86 | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-304479-uxp1kg86 | Can cell therapies halt cytokine storm in severe COVID-19 patients? |
| cord-310205-j57x9ke6 | : abscess of cellulitis? |
| cord-310205-j57x9ke6 | A cost- effectiveness analysis of diagnosis and management of adults with pharyngitis Diagnosing strep throat in the adult patient: do clinical criteria really suffice? |
| cord-310205-j57x9ke6 | Antibiotics for sore throat Are cephalosporins superior to penicillin for treatment of acute streptococcal pharyngitis? |
| cord-310205-j57x9ke6 | Definition of a clinical illness associated with seroconversion Primary HIV infection Clinical presentations and virologic characteristics of primary human immunodeficiency virus type-1 infection in a university hospital in Taiwan Clinical picture of HIV infection presenting as a glandular- fever- like illness Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? |
| cord-310205-j57x9ke6 | The role of streptococcus in the pathogenesis of rheumatic fever Rapid diagnosis of pharyngitis caused by group A streptococci Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis Management of acute pharyngitis in adults: reliability of rapid streptococcal tests and clinical findings Treatment failures and carriers: perception or problems? |
| cord-274283-ukhgs6z1 | = COVID-19?AND?clinical?characterstic? |
| cord-274283-ukhgs6z1 | The database used in the study is publicly available and can be found at https:// pubmed.ncbi.nlm.nih.gov/?term=COVID-19? |
| cord-274283-ukhgs6z1 | The database used in the study is publicly available and can be found at https://pubmed.ncbi.nlm.nih.gov/? |
| cord-274283-ukhgs6z1 | What was learned from the study? |
| cord-274283-ukhgs6z1 | Why carry out this study? |
| cord-293151-g3758oes | : what is the correct value for the calculation of metabolic body weight in dogs? |
| cord-293151-g3758oes | An emerging pulmonary haemorrhagic syndrome in dogs: similar to the human leptospiral pulmonary haemorrhagic syndrome? |
| cord-293151-g3758oes | What's your diagnosis? |
| cord-293151-g3758oes | a retrospective study Canine cutaneous epitheliotropic T- cell lymphoma: a review Canine infectious respiratory disease Helicobacter- associated gastric disease in ferrets, dogs, and cats Enteric bacterial infections Hemorrhagic streptococcal pneumonia in newly procured research dogs Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners Reproductive patterns in the domestic dog- a retrospective study of the Drever breed The dog as a research subject A review of canine pseudocyesis Leptospirosis Surgical treatment of an elbow hygroma utilizing microvascular free muscle transfer in a newfoundland Bacterial diseases Immunoprophylaxis Leptospirosis Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health Non- Helicobacter pylori Helicobacter species in the human gastric mucosa: a proposal to introduce the terms H. heilmannii sensu lato and sensu stricto Diseases of the small intestine Histotripsy of the prostate: dose effects in a chronic canine model Flea control failure? |
| cord-293151-g3758oes | which chemotherapy protocol and why? |
| cord-316647-jj8anf5g | Does pulse pressure variation predict fluid responsiveness in critically ill patients? |
| cord-316647-jj8anf5g | The convalescent sera option for containing COVID-19 Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-316647-jj8anf5g | Use of convalescent plasma therapy in SARS patients in Hong Kong Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience Treatment of 5 critically ill patients with COVID-19 with convalescent plasma Effectiveness of convalescent plasma therapy in severe COVID-19 patients Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-316647-jj8anf5g | a study on coronary artery bypass graft surgery patients Monitoring sound and light continuously in an intensive care unit patient room: a pilot study The efficacy of earplugs as a sleep hygiene strategy for reducing delirium in the ICU: a systematic review and meta- analysis Effect of dexmedetomidine added to standard care on ventilatorfree time in patients with agitated delirium: a randomized clinical trial Melatonin decreases delirium in elderly patients: a randomized, placebo- controlled trial Preventive effects of ramelteon on delirium: a randomized placebo- controlled trial Melatonin, ramelteon, suvorexant, and dexmedetomidine to promote sleep and prevent delirium in critically ill patients: a narrative review with practical applications Interpreting and implementing the 2018 pain, agitation/ sedation, delirium, immobility, and sleep disruption clinical practice guideline Sedation with sufentanil in patients receiving pressure support ventilation has no effects on respiration: a pilot study Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? |
| cord-276495-q22jnkn2 | Could BCG vaccination be a more promising therapeutic alternative than chloroquine? |
| cord-276495-q22jnkn2 | Dr. Netea said that preliminary results showed that in a large number of human volunteer cohorts, the BCG vaccine induced trained immunity( 450%; as stated in https://www.youtube.com/watch? |
| cord-276495-q22jnkn2 | How is memory in CD8+ T cells formed chemically? |
| cord-276495-q22jnkn2 | However, the big question is,''how are antibodies produced against an infectious pathogen or vaccine?'' |
| cord-276495-q22jnkn2 | Is innate memory more effective against SARS- CoV-2 than acquired memory? |
| cord-276495-q22jnkn2 | a database of global BCG vaccination policies and practices Is BCG vaccination causally related to reduced COVID-19 mortality? |
| cord-023528-z9rc0ubj | A prospective study of septicaemia in colostrum- deprived foals Care of the gut in the surgical intensive care unit: fact or fashion? |
| cord-023528-z9rc0ubj | Acute renal failure in children: aetiology and management Low- dose dopamine in the intensive care unit: DNR or DNRx? |
| cord-023528-z9rc0ubj | Endoscopic and virological observations on respiratory disease in a group of young thoroughbred horses in training Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals? |
| cord-023528-z9rc0ubj | Overwhelming strongyloidosis in a foal Verminous arteritis in a 3-month- old thoroughbred foal Randomised trial of fluid restriction in ventilated very low birthweight infants Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants Hyponatraemia in children with acute CNS disease: SIADH or cerebral salt wasting? |
| cord-023528-z9rc0ubj | The protective role of gastric acidity in neonatal bacterial translocation Upper gastrointestinal tract bleeding in critically ill pediatric patients Gastric colonization as a consequence of stress ulcer prophylaxis: a prospective, randomized trial Is prophylaxis for gastric ulcers necessary in critically ill equine neonates? |
| cord-023528-z9rc0ubj | a review Clinical syndromes of gastric ulceration in foals and mature horses Gastroduodenal ulceration in foals Stress ulcer: is routine prophylaxis necessary? |
| cord-319933-yp9ofhi8 | * Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome SARS vaccines: where are we? |
| cord-319933-yp9ofhi8 | An unusual hantavirus outbreak in southern Argentina: person- to- person transmission? |
| cord-319933-yp9ofhi8 | Efficacy assessment of a cell- mediated immunity HIV-1 vaccine( the step study): a double- blind, randomised, placebo- controlled, test- of- concept trial Human papillomavirus in cervical cancer Human papillomavirus research: do we still need animal models? |
| cord-319933-yp9ofhi8 | Phenotypic changes in Langerhans'cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? |
| cord-015334-8p124rwp | It is impossible to analyse a nonresponse of our recommendations: is our advice even red, is it considered as inadequate? |
| cord-015334-8p124rwp | What are the experiences of patients? |
| cord-015334-8p124rwp | What does current information provision on antidepressants to patients with a depression admitted to a psychiatric hospital look like? |
| cord-015334-8p124rwp | What is the current practice of health care professionals? |
| cord-015334-8p124rwp | anti- References Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on- line column- switching Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube Is the administration of esomeprazole through a nasogastric tube modified by concomitant delivery of a nutrition mixture? |
| cord-015334-8p124rwp | … where do we stand? |
| cord-343715-y594iewi | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-343715-y594iewi | CT and MRI features Guillain- Barré syndrome associated with SARS- CoV-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-343715-y594iewi | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-343715-y594iewi | The Heart in COVID19: primary target or secondary bystander? |
| cord-350793-bftztg0e | : Beyond the running median Alarms in the intensive care unit: How can the number of false alarms be reduced? |
| cord-350793-bftztg0e | How do they perform in clinical practice? |
| cord-350793-bftztg0e | Why does n't healthcare embrace simulation and modeling? |
| cord-350793-bftztg0e | Why should we integrate biomarkers into complex trials? |
| cord-316432-xemz7zn9 | : cord-316432-xemz7zn9 authors: Talaie, Haleh; Hosseini, Sayed Masoud; Nazari, Maryam; Fakhri, Yadollah; Mousavizadeh, Atieh; Vatanpour, Hossein; Firoozfar, Ali title: Is there any potential management against COVID-19? |
| cord-316432-xemz7zn9 | A commentary on World Health Organization declares global emergency: A review of the 2019 novel Coronavirus( COVID-19) Outbreak of COVID-19-an urgent need for good science to silence our fears? |
| cord-316432-xemz7zn9 | Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: |
| cord-316432-xemz7zn9 | Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Lack of Efficacy of Hydroxychloroquine or Azithromycin on COVID-19 Clinical Course Coronavirus disease 2019( COVID-19): a clinical updateThe epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures Favipiravir, an antiviral for COVID-19? |
| cord-316432-xemz7zn9 | Should chloroquine and hydroxychloroquine be used to treat COVID-19? |
| cord-316432-xemz7zn9 | what we know so far Baricitinib for COVID-19: a suitable treatment? |
| cord-315730-fzgxuak7 | Gilead Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-315730-fzgxuak7 | Lessons from Other Coronavirus Strains Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ ritonavir Saunders Handbook of Veterinary Drugs Interaction between antihypertensives and NSAIDs in primary care: a controlled trial Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19 A review of the safety of favipiravir-a potential treatment in the COVID-19 pandemic? |
| cord-315730-fzgxuak7 | PHOSPHATE Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-315730-fzgxuak7 | The Lancet Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients? |
| cord-315730-fzgxuak7 | What if I take an extra contraceptive pill by accident? |
| cord-315730-fzgxuak7 | Why your health may never be the same after Covid-19. Retrieved from Swedish Orphan Biovitrum Ltd Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo- controlled phase III trial in Japan Hydroxychloroquine in patients with COVID-19: an open- label, randomized Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis Mechanism of Inhibition of Ebola Virus RNA- Dependent RNA Polymerase by Remdesivir Interferon and cytokine responses to SARS- coronavirus infection Antihypertensive drugs and risk of COVID-19? |
| cord-347189-i9rzo3j0 | At what cost to clinical trial enrollment? |
| cord-347189-i9rzo3j0 | Directive really improve clinical trial approval time? |
| cord-347189-i9rzo3j0 | Virtually perfect? |
| cord-347189-i9rzo3j0 | will the pandemic lead to change? |
| cord-022526-j9kg00qf | , why does the iced tea have a garlic taste? |
| cord-022526-j9kg00qf | : what happens in the microcompartments? |
| cord-022526-j9kg00qf | How important is intestinal reperfusion injury in horses? |
| cord-022526-j9kg00qf | Is Helicobacter( Campylobacter) pylori associated with gastritis/ ulcer disease in asymptomatic foals? |
| cord-022526-j9kg00qf | The oral glucose tolerance test in the horse Small intestinal malabsorption in the horse: an assessment of the specificity of the oral glucose tolerance test Transient glucose malabsorption in two horses: fact or artifact? |
| cord-022526-j9kg00qf | The role of cyclooxygenase inhibitors in repair of ischaemic- injured jejunal mucosa in the horse Mechanisms of acute and chronic intestinal inflammation induced by indomethacin Mechanisms of NSAID- induced gastrointestinal injury defined using mutant mice Pathogenesis of NSAID gastropathy: are neutrophils the culprits? |
| cord-353330-j00jj2og | A slippery slope? |
| cord-353330-j00jj2og | Serum as a"standard"? |
| cord-353330-j00jj2og | Time to think big in human biology? |
| cord-353330-j00jj2og | What is a standard? |
| cord-353330-j00jj2og | When was the last time you've seen these words? |
| cord-276255-0ofsa40u | 4, 5 But what of clinical pharmacy? |
| cord-276255-0ofsa40u | Similarly, when a service can be withdrawn during a time of crisis, is it still essential? |
| cord-276255-0ofsa40u | The experiences of health- care providers during the COVID-19 crisis in China: a qualitative study COVID-19 significantly impacts health services for noncommunicable diseases million elective surgeries may be cancelled worldwide: how non- COVID-19 medical care is suffering SARS- CoV-2 outbreak: How can pharmacists help? |
| cord-276255-0ofsa40u | We have consultants come up to us asking tough questions sometimes such as,'Why are the French using 600 mg of hydroxychloroquine?' |
| cord-276255-0ofsa40u | or'How do statins interact with these antivirals, exactly?' |
| cord-276255-0ofsa40u | or'Which is better, chloroquine or hydroxychloroquine?' |
| cord-276255-0ofsa40u | questions: Where clinical pharmacists are not allowed patient contact in the wards, or not provided adequate PPE because both of these have been restricted to'essential'staff, are they then considered'optional'? |
| cord-029332-yn603pvb | COVID-19 pneumonia: a random association? |
| cord-029332-yn603pvb | COVID-19 pneumonia: a random association? |
| cord-029332-yn603pvb | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Direct oral anticoagulants for the treatment of left ventricular thrombus- a new indication? |
| cord-029332-yn603pvb | Intraventricular thrombus and severe mitral regurgitation in the acute phase of Takotsubo cardiomyopathy: two case reports Endothelial cell infection and endotheliitis in COVID-19 ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-029332-yn603pvb | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-029332-yn603pvb | what next? |
| cord-029332-yn603pvb | what next? |
| cord-029332-yn603pvb | where are the heart attacks and strokes? |
| cord-336554-n8n5ii5k | An analysis based on decade- long structural studies of SARS Do viral infections mimic bacterial sepsis? |
| cord-336554-n8n5ii5k | COVID-19 treatment by repurposing drugs until the vaccine is in sight Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications ACE 2: more of Ang 1- 7 or less Ang II? |
| cord-336554-n8n5ii5k | COVID-19? |
| cord-336554-n8n5ii5k | Dexamethasone for COVID-19? |
| cord-336554-n8n5ii5k | Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS- CoV-2 RNA dependent RNA polymerase( RdRp): a molecular docking study Computational target- based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS- CoV-2 proteins COVID-19 and chronological aging: senolytics and other anti- aging drugs for the treatment or prevention of corona virus infection? |
| cord-336554-n8n5ii5k | an open- label, randomised, phase 2 trial Mechanisms of coronavirus cell entry mediated by the viral spike protein SARS- CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-353528-8a3f5hxu | Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? |
| cord-353528-8a3f5hxu | Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? |
| cord-353528-8a3f5hxu | Does a negative phase III trial of random donor mesenchymal stromal cells in steroid- resistant graft- versus- host disease represent a death knell or a bump in the road? |
| cord-353528-8a3f5hxu | Does vitamin C have the ability to augment the therapeutic effect of bone marrow- derived mesenchymal stem cells on spinal cord injury? |
| cord-353528-8a3f5hxu | Mesenchymal stem cells are injured by complement after their contact with serum Complement and coagulation: Strangers or partners in crime? |
| cord-353528-8a3f5hxu | Mesenchymal stromal cell homing: Mechanisms and strategies for improvement Bioengineering strategies to accelerate stem cell therapeutics How to improve the survival of transplanted mesenchymal stem cell in ischemic heart? |
| cord-003316-r5te5xob | -what is an achievable turnaround time? |
| cord-003316-r5te5xob | Can current expertise in traditional clinical microbiology be maintained in the transition to WGS? |
| cord-003316-r5te5xob | How can clinical metagenomic data be managed safely in line with the ethical considerations applicable to identifiable human DNA? |
| cord-003316-r5te5xob | How can publicly available databases be reliably maintained to the required clinical accreditation standards over long time periods? |
| cord-003316-r5te5xob | How can unwieldy bioinformatics pipelines developed with academic research in mind be adapted for a clinical setting? |
| cord-003316-r5te5xob | Though, we can see an opportunity for low-/medium- income countries to Outstanding Questions Can WGS be used to develop robust classification schemes that account for the genetic diversity of organisms with open genomes? |
| cord-003316-r5te5xob | When are pathogen genome sequences informative of transmission events? |
| cord-003316-r5te5xob | Which clinically relevant phenotypes can be reliably predicted using WGS, and for which organisms? |
| cord-003316-r5te5xob | Will the true cost of generating a bacterial genome remain stable as the sequencing market consolidates in fewer hands? |
| cord-003316-r5te5xob | analyses of outbreaks be speeded up to meaningfully contribute to infection control at actionable time scales? |
| cord-317952-4oa9hfb4 | All rights reserved Quantitative proteomic analysis reveals the deregulation of nicotinamide adenine dinucleotide metabolism and CD38 in inflammatory bowel disease Upregulation of circulating components of the alternative renin- angiotensin system in inflammatory bowel disease: A pilot study Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-317952-4oa9hfb4 | COVID-19 concern nephrologists? |
| cord-317952-4oa9hfb4 | Covid-19: risk factors for severe disease and death Cyclosporin A inhibits the replication of diverse coronaviruses COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-317952-4oa9hfb4 | Preventing a covid-19 pandemic Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-317952-4oa9hfb4 | Renin- angiotensin- aldosterone system inhibitors in patients with Covid-19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-317952-4oa9hfb4 | Why and to what extent? |
| cord-317952-4oa9hfb4 | causative or coincidental? |
| cord-317952-4oa9hfb4 | induced pneumonia and macrophage activation syndrome- like disease A combined set of four serum inflammatory biomarkers reliably predicts endoscopic disease activity in inflammatory bowel disease Tocilizumab treatment in COVID-19: A single center experience Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab Off- label use of tocilizumab in patients with SARS- CoV-2 infection Preventing COVID-19-induced pneumonia with anticytokine therapy Baricitinib for COVID-19: a suitable teatment? |
| cord-318209-llucxztc | Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilatorinduced lung injury Intravenous mesenchymal stem cell therapy for traumatic brain injury Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first- pass effect Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting Translational applications of tissue engineering in cardiovascular medicine Extracellular matrix and regenerative therapies from the cardiac perspective Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke( MASTERS): a randomised, double- blind, placebo- controlled, phase 2 trial Strategies for improving animal models for regenerative medicine Can animal models of disease reliably inform human studies? |
| cord-318209-llucxztc | MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Extracellular vesicles or exosomes? |
| cord-318209-llucxztc | Mesenchymal stem cell infusion shows promise for combating coronavirus( COVID-19)-induced pneumonia Mesenchymal stromal cell secretome for severe COVID-19 infections: premises for the therapeutic use Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia Mesenchymal stem cells for coronavirus( COVID-19)-induced pneumonia: revisiting the paracrine hypothesis with new hopes? |
| cord-318209-llucxztc | Nonventilatory treatments for acute lung injury and ARDS Clinical review: Stem cell therapies for acute lung injury/ acute respiratory distress syndrome-hope or hype? |
| cord-318209-llucxztc | Possible role of exosomes containing RNA in mediating nontargeted effect of ionizing radiation Extracellular vesicles mediate radiationinduced systemic bystander signals in the bone marrow and spleen Endometrial regenerative cells and exosomes thereof for treatment of radiation exposure Cranial grafting of stem cellderived microvesicles improves cognition and reduces neuropathology in the irradiated brain Macrophages educated with exosomes from primed mesenchymal stem cells treat acute radiation syndrome by promoting hematopoietic recovery Initial evaluation and management of the critical burn patient Burn support for Operation Iraqi Freedom and related operations Stem cells in skin regeneration, wound healing, and their clinical applications Stem cell therapy: a new treatment for burns? |
| cord-318209-llucxztc | Systemic immune response to traumatic cns injuries- are extracellular vesicles the missing link? |
| cord-318209-llucxztc | The challenge of bringing iPSCs to the patient One, two, three steps toward cell therapy for stroke Concise review: stem cell therapy for stroke patients: are we there yet? |
| cord-318209-llucxztc | mesenchymal stromal/ stem cells: a new treatment for sepsis and septic shock? |
| cord-318209-llucxztc | progress and challenges Trends in mesenchymal stem cell clinical trials 2004- 2018: is efficacy optimal in a narrow dose range? |
| cord-316886-qzka2dqm | A typology of ethical problems faced by house officers A national study of ethics committees Clinical ethics consultation in the United Kingdom Is evaluating ethics consultation on the basis of cost a good idea? |
| cord-316886-qzka2dqm | Can UK clinical ethics committees improve quality of care? |
| cord-316886-qzka2dqm | Clinician support or crisis management? |
| cord-316886-qzka2dqm | How can we know that ethics education produces ethical doctors? |
| cord-316886-qzka2dqm | How should doctors use e- portfolios in the wake of the Bawa- Garba case? |
| cord-316886-qzka2dqm | Is organizational ethics the remedy for failure to thrive? |
| cord-316886-qzka2dqm | Supporting doctors in the emotional labour of clinical care What could make a difference to the mental health of UK doctors? |
| cord-316886-qzka2dqm | What do they do, and does it make a difference? |
| cord-316886-qzka2dqm | What outcomes do Dutch healthcare professionals perceive as important before participation in moral case deliberation? |
| cord-327738-i400ynjp | COVID-19 outbreak Are we harming cancer patients by delaying their cancer surgery during the COVID-19 pandemic? |
| cord-327738-i400ynjp | Could the pandemic inappropriately skew the results? |
| cord-327738-i400ynjp | If we continue such clinical trials, are we putting patients at greater risk of COVID19-related complications? |
| cord-327738-i400ynjp | If we expedite and prioritize surgical treatment for those patients who are part of a trial, are we unduly pressuring them to participate( a form of coercion)? |
| cord-327738-i400ynjp | In contrast,, is it ethical to suspend future enrollment or active participation if it would potentially deny patients the benefit of novel therapeutic interventions or improved outcomes associated with the clinical trial? |
| cord-327738-i400ynjp | Specifically, is it ethically appropriate to continue enrollment and treatment of patients in clinical trials that include surgical intervention? |
| cord-327738-i400ynjp | What is the ethical basis for supporting this decision even though it means that some patients are not getting the latest and potentially more effective devices to treat their vascular disease? |
| cord-327738-i400ynjp | cord-327738-i400ynjp authors: Milner, Ross; Donington, Jessica; Matthews, Jeffrey; Posner, Mitchell; Turaga, Kiran; Angelos, Peter title: Is it Ethically Appropriate to Continue Surgical Clinical Trials During the COVID-19 Pandemic? |
| cord-344705-co0nk7pt | Aside from the important resource issue and the ethical issue of having to enrol so many patients in small, individual control groups, we raise another obvious concern: can these trials possibly deliver? |
| cord-344705-co0nk7pt | Could we have gleaned more useful information from the fate of those same 61 patients by including them in a well- coordinated multi- arm trial? |
| cord-344705-co0nk7pt | Even early on during the pandemic, the question has rightly been asked"Do we need 300 trials? |
| cord-344705-co0nk7pt | However, as drug regulators, we ask: how many of the ongoing trials will be able to support robust regulatory( and individual treatment) decisions? |
| cord-344705-co0nk7pt | Is that a good use of resources? |
| cord-344705-co0nk7pt | Is this condition met by a small,( underpowered) standalone trial, perhaps with a high probability of failure due to lack of enrolment? |
| cord-344705-co0nk7pt | Or could the objective be better met by redirecting the energy to one of the larger ongoing trials? |
| cord-344705-co0nk7pt | Why has this not happened to a larger extent and what are the possible reasons behind the fragmented trial landscape, globally and in the EU? |
| cord-344705-co0nk7pt | authors: Eichler, Hans‐Georg; Cavaleri, Marco; Enzmann, Harald; Scotti, Francesca; Sepodes, Bruno; Sweeney, Fergus; Vamvakas, Spiros; Rasi, Guido title: Clinical trials for Covid‐19: can we better use the short window of opportunity? |
| cord-022754-ehq9qnoo | A review Breed, sex and age distribution in dogs with chronic liver disease: a demographic study Chronic hepatitis in Cocker Spaniels- another syndrome? |
| cord-022754-ehq9qnoo | Fad or future of liver disease? |
| cord-022754-ehq9qnoo | Information provided by a scintigram is a"yes"or"no"answer to the question: Does the patient have portosystemic shunting? |
| cord-022754-ehq9qnoo | Is hepatic impairment a clue to pathogenesis? |
| cord-022754-ehq9qnoo | Statistical relevance of ultrasonographic criteria in the assessment of diffuse liver disease in dogs and cats Can sonographic findings predict the results of liver aspirates in dogs with suspected liver disease? |
| cord-022754-ehq9qnoo | The pathology of liver tumours in the dog Partial hepatectomy in dogs Cancer of the liver Efficacy of mitoxantrone against various neoplasms in dogs Low- dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells? |
| cord-022754-ehq9qnoo | The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs Chronic active hepatitis with cirrhosis in the Doberman Pinscher Hepatic copper concentrations in Labrador Retrievers with and without chronic hepatitis( 1980- 2008): an emerging syndrome or oversupplementation? |
| cord-022754-ehq9qnoo | With suspected drug- or toxin- induced liver disease, a liver biopsy can be helpful to( a) characterize the histologic changes( are they consistent with previously described lesions caused by this particular drug or toxin?),( b) determine the severity( focal or diffuse necrosis?) or reversibility( is cirrhosis present?) of the lesions for prognostic purposes, and( c) rule out known causes of liver disease. |
| cord-022754-ehq9qnoo | With suspected drug- or toxin- induced liver disease, a liver biopsy can be helpful to( a) characterize the histologic changes( are they consistent with previously described lesions caused by this particular drug or toxin?),( b) determine the severity( focal or diffuse necrosis?) or reversibility( is cirrhosis present?) of the lesions for prognostic purposes, and( c) rule out known causes of liver disease. |
| cord-022754-ehq9qnoo | With suspected drug- or toxin- induced liver disease, a liver biopsy can be helpful to( a) characterize the histologic changes( are they consistent with previously described lesions caused by this particular drug or toxin?),( b) determine the severity( focal or diffuse necrosis?) or reversibility( is cirrhosis present?) of the lesions for prognostic purposes, and( c) rule out known causes of liver disease. |
| cord-018335-4l7scdqk | 2009 update by the Infectious Diseases Society of America T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial T2 magnetic resonance: a diagnostic platform for studying integrated hemostasis in whole blood- proof of concept Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of candida species using seeded blood samples Automation in clinical microbiology Point- counterpoint: the automated clinical microbiology laboratory: fact of fantasy? |
| cord-018335-4l7scdqk | Are viral cultures and antigen based testing truly needed in a clinical microbiology/ virology laboratory since molecular methods are becoming the new gold standard? |
| cord-018335-4l7scdqk | Automation in the clinical microbiology laboratory Emerging technologies for the clinical microbiology laboratory Laboratory automation in clinical microbiology: a quiet revolution Automation in clinical bacteriology: what system to choose? |
| cord-018335-4l7scdqk | Do hospitalist physicians improve quality of inpatient care delivery? |
| cord-018335-4l7scdqk | Is bigger necessarily better? |
| cord-018335-4l7scdqk | New quick and cheap bedside test for cortisol uses smartphone Can hospital rounds with pocket ultrasound by cardiologists reduce standard echocardiology? |
| cord-018335-4l7scdqk | Should the qualitative serum pregnancy test be considered obsolete? |
| cord-018335-4l7scdqk | Utilization of assay performance characteristics to estimate hemoglobin A1C result reliability Performance of hemoglobin A1C assay methods: good enough? |
| cord-018335-4l7scdqk | Why disruptive innovations matter in laboratory diagnostics Pathology resident and fellow education in a time of disruptive technologies Role of cell culture for virus detection in the age of technology Replacement of biologic by molecular techniques in diagnostic virology: thirty years after the advent of PCR technology- do we still need conventional methods? |
| cord-018335-4l7scdqk | Why was there an exceptionally low NG volume from Hospital B? |
| cord-018335-4l7scdqk | computerized physician order entry system order sets drive ordering habits Hospital industry consolidation- still more to come? |
| cord-342756-rgm9ffpk | -What happens next? |
| cord-342756-rgm9ffpk | : what to expect for COVID-19? |
| cord-342756-rgm9ffpk | COVID-19 and diabetes: Can DPP4 inhibition play a role? |
| cord-342756-rgm9ffpk | COVID-19, SARS and MERS: are they closely related? |
| cord-342756-rgm9ffpk | DPP4 inhibition: preventing SARS- CoV-2 infection and/or progression of COVID-19? |
| cord-342756-rgm9ffpk | Protein- protein interactions of viroporins in coronaviruses and paramyxoviruses: new targets for antivirals? |
| cord-342756-rgm9ffpk | The importance of hypertension as a risk factor for severe illness and mortality in COVID-19 Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study Diabetes is a risk factor for the progression and prognosis of COVID-19 Older people and COVID-19: isolation, risk and ageism Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow- up Drug repositioning: identifying and developing new uses for existing drugs Drug repurposing from the perspective of pharmaceutical companies Drug repurposing: progress, challenges and recommendations Emerging virus diseases: can we ever expect the unexpected? |
| cord-342756-rgm9ffpk | and COVID-19: serendipity or opportunity for intervention? |
| cord-342756-rgm9ffpk | should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-342756-rgm9ffpk | what lessons have we learned? |
| cord-274802-7ioiwsd8 | : what to expect for COVID-19? |
| cord-274802-7ioiwsd8 | COVID-19 Hyperinflammation: What about Neutrophils? |
| cord-274802-7ioiwsd8 | COVID-19 pandemic and the skin: what should dermatologists know? |
| cord-274802-7ioiwsd8 | Effects of chloroquine on viral infections: An old drug against today's diseases? |
| cord-274802-7ioiwsd8 | How far the lung surfactant system gets affected during severe symptoms? |
| cord-274802-7ioiwsd8 | Lessons from atypical haemolytic uraemic syndrome Complement- mediated endothelial cell damage in immune complex vasculitis of the skin: Ultrastructurallocalization of the membrane attack complex Mannose- Binding Lectin in Severe Acute Respiratory Syndrome Coronavirus Infection Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over- activation The complement system in COVID-19: friend and foe? |
| cord-274802-7ioiwsd8 | On the adaptive immune aspects, what variations exist within population in terms of the proportion of neutralising antibodies? |
| cord-274802-7ioiwsd8 | Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease SARS- CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study Why does COVID-19 disproportionately affect older people? |
| cord-274802-7ioiwsd8 | What are the genetic contributors to susceptibility and resistance to developing COVID-19? |
| cord-274802-7ioiwsd8 | What happens during the period of latency, i.e. between being infected and showing symptoms? |
| cord-274802-7ioiwsd8 | Where and What Is the Evidence? |
| cord-274802-7ioiwsd8 | Why there are a huge population that are asymptomatic carriers? |
| cord-274802-7ioiwsd8 | observational cohort study Loss of smell and taste as symptoms of COVID-19: what does the evidence say? |
| cord-289520-i6pv90s9 | What are risk factors for death or severe illness? |
| cord-289520-i6pv90s9 | What are the risk factors for death or severe illness? |
| cord-289520-i6pv90s9 | What are the risk factors for death or severe illness? |
| cord-289520-i6pv90s9 | What are the risk factors for infection( in patient population)? |
| cord-289520-i6pv90s9 | What characteristics define a"case"? |
| cord-289520-i6pv90s9 | What is the causative agent of disease? |
| cord-289520-i6pv90s9 | What is the causative agent of disease? |
| cord-289520-i6pv90s9 | What is the causative agent of disease? |
| cord-289520-i6pv90s9 | What is the clinical presentation and spectrum of disease? |
| cord-289520-i6pv90s9 | What is the duration of viral shedding? |
| cord-289520-i6pv90s9 | What is the optimal diagnostic test for detecting the virus? |
| cord-289520-i6pv90s9 | What is the optimal diagnostic test? |
| cord-289520-i6pv90s9 | What is the role of antivirals in treatment? |
| cord-289520-i6pv90s9 | What is the role of steroids in treatment? |
| cord-289520-i6pv90s9 | What risk factors pre- dispose health care workers to infection or transmission? |
| cord-289520-i6pv90s9 | What treatments are effective? |
| cord-325559-di8lljoi | Does SARS- CoV-2 Trigger Stress- Induced Autoimmunity by Molecular Mimicry? |
| cord-325559-di8lljoi | Furthermore, can there be protective factors? |
| cord-325559-di8lljoi | Furthermore, can there be protective factors? |
| cord-325559-di8lljoi | Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
| cord-325559-di8lljoi | It Is Pneumonia? |
| cord-325559-di8lljoi | The Columbus'egg? |
| cord-325559-di8lljoi | What are the main clues that epidemiology and the clinics provide to date? |
| cord-325559-di8lljoi | What are the predisposing factors? |
| cord-325559-di8lljoi | What are the predisposing factors? |
| cord-325559-di8lljoi | What proteins? |
| cord-325559-di8lljoi | What proteins? |
| cord-325559-di8lljoi | Which cells? |
| cord-325559-di8lljoi | Which cells? |
| cord-325559-di8lljoi | Why should severe acute respiratory syndrome coronavirus 2( SARS- CoV-2) not be considered one of these? |
| cord-345371-pjbviagq | : Are we asking the right questions? |
| cord-345371-pjbviagq | An Individual Patient Data Systematic Review Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| cord-345371-pjbviagq | An Overview of Severe Acute Respiratory Syndrome- Coronavirus( SARS- CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad- Spectrum Therapeutic Strategy Old drugs as lead compounds for a new disease? |
| cord-345371-pjbviagq | Baricitinib: a chance to treat COVID-19? |
| cord-345371-pjbviagq | Bleeding and Thrombotic Manifestations of SARS- CoV2 Infection COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow- up Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? |
| cord-345371-pjbviagq | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-345371-pjbviagq | Increased cardiovascular mortality in African Americans with COVID-19 Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis? |
| cord-345371-pjbviagq | Inhibitory Mechanisms A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Owa Lopinavir/ ritonavir use in Covid-19 infection: is it completely non- beneficial? |
| cord-345371-pjbviagq | Is teicoplanin a complementary treatment option for COVID-19? |
| cord-345371-pjbviagq | Justified? |
| cord-345371-pjbviagq | Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-345371-pjbviagq | The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells Cardiac arrest caused by nafamostat mesilate Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy Potential new treatment strategies for COVID-19: is there a role for bromhexine as add- on therapy? |
| cord-345371-pjbviagq | Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? |
| cord-345371-pjbviagq | Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors Angiotensin- I converting enzyme inhibitors as potential anti- angiogenic agents for cancer therapy Our ACE in the HOLE: Justifying the Use of Angiotensin- converting Enzyme Inhibitors as Adjuvants to Standard Chemotherapy Vascular endothelial growth factor( VEGF) in acute lung injury( ALI) and acute respiratory distress syndrome( ARDS): paradox or paradigm? |
| cord-345371-pjbviagq | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-022555-a7ie82fs | Abdominal palpation should be performed to assess pain( where?), any masses( foreign bodies, lymph nodes, or even focally thickened intestines, such as with neoplasia), or turgid intestines. |
| cord-022555-a7ie82fs | Acute pancreatitis in cats with hepatic lipidosis Pancreatic atrophy and fibrosis associated with Eurytrema procyonis in a domestic cat Comparisons between cats with normal and increased fPLI concentrations in cats diagnosed with inflammatory bowel disease Pancreatolithiasis and pancreatic pseudobladder associated with pancreatitis in a cat Acinar cell carcinoma of the pancreas in a cat Laparotomy for gastro- intestinal biopsies Enteric bacteria: friend or foe? |
| cord-022555-a7ie82fs | Appearance of diarrhea Quantity and quality of the stool( color, consistency, character, presence of blood or mucus)? |
| cord-022555-a7ie82fs | Are any medications required? |
| cord-022555-a7ie82fs | Are lilies present in the house? |
| cord-022555-a7ie82fs | Are such patients best treated for inflammatory bowel disease, Helicobacter infection, or both? |
| cord-022555-a7ie82fs | Are there any dietary changes or indiscretion? |
| cord-022555-a7ie82fs | Are there any medications unaccounted for( e.g., a dropped aspirin tablet)? |
| cord-022555-a7ie82fs | Description of defecation process Tenesmus( straining) and dyschezia( painful defecation)? |
| cord-022555-a7ie82fs | Has the cat been seen playing with an insect, mouse, or other prey? |
| cord-022555-a7ie82fs | Important questions to ask concern frequency of defecation( and how this compares with the normal state), tenesmus( straining usually indicates large bowel diarrhea, since an irritated colon leads to urgency), volume of feces( smaller volumes are typical of large bowel diarrhea; larger volumes are more typical of small Onset and duration of diarrhea Acute versus chronic? |
| cord-022555-a7ie82fs | Is supportive care necessary? |
| cord-022555-a7ie82fs | Is the cat well or unwell? |
| cord-022555-a7ie82fs | Is there primary or secondary gastrointestinal disease? |
| cord-022555-a7ie82fs | Is there small or large bowel diarrhea? |
| cord-022555-a7ie82fs | The practitioner must ask the following important questions: • Are ancillary tests appropriate? |
| cord-022555-a7ie82fs | • Is there an acute onset or a chronic time course? |
| cord-350571-6tapkjb6 | DI012: Wikipedia and medicines: who edits medicine articles on the English Wikipedia? |
| cord-350571-6tapkjb6 | Does a hospital formulary system impact timely medication administration and quality of inpatient care? |
| cord-350571-6tapkjb6 | From those who were treated by TMP/ SMX, following data were collected: age, gender, weight, doses, and indications( probabilistic? documented? |
| cord-350571-6tapkjb6 | From those who were treated by TMP/ SMX, following data were collected: age, gender, weight, doses, and indications( probabilistic? documented? |
| cord-350571-6tapkjb6 | From those who were treated by carbapenems, PIP/ TAZ or AMX AC, following data were collected: age, gender, weight, doses, indications( probabilistic? documented? |
| cord-350571-6tapkjb6 | From those who were treated by carbapenems, PIP/ TAZ or AMX AC, following data were collected: age, gender, weight, doses, indications( probabilistic? documented? |
| cord-350571-6tapkjb6 | HP- PC015: Discharged patients: a problem for community pharmacists? |
| cord-350571-6tapkjb6 | HP- PC027: QT- prolongation in an acute psychiatric setting: fact or fiction? |
| cord-350571-6tapkjb6 | HP- PC068: Are hospital pharmaceutical staff educated on the criticality of thermosensitive drugs? |
| cord-350571-6tapkjb6 | HP- PC134: How the centralization of medicines manufacturing enable to generalize the pharmaceutical validation? |
| cord-350571-6tapkjb6 | Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression and Monte Carlo simulations: is it plausible? |
| cord-350571-6tapkjb6 | On the question''What is your general perception of the benefit of the clinical pharmacy service; for collaborating health professionals? |
| cord-350571-6tapkjb6 | Personal changes in drug regimen: dangerous for health system? |
| cord-350571-6tapkjb6 | The office of access to healthcare: how to optimize secured access to treatments? |
| cord-350571-6tapkjb6 | The open questions:''What disadvantages/ advantages have you experienced by the introduction of clinical pharmacist into multidisciplinary teams?''received 153/185 comments respectively. |
| cord-350571-6tapkjb6 | The research questions were: When comparing dicloxacillin with other antibiotics commonly used in children,( 1) is there a difference in the age of conversion from liquid to solid formulation and( 2) is there a difference in re- prescription rates on day 1 and 2 after the initial prescription? |
| cord-350571-6tapkjb6 | for the patient?''the total benefit was ranked 5.45 and 5.54 respectively( Scale from 0(''no benefit'') to 6(''beneficial to a very large extent''). |
| cord-334773-yw2qgv13 | COVID-19 and diabetes management: What should be considered? |
| cord-334773-yw2qgv13 | COVID-19: consider cytokine storm syndromes and immunosuppression COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-334773-yw2qgv13 | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-334773-yw2qgv13 | Considerations for obesity, vitamin D, and physical activity amid the COVID-19 pandemic Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms Does high cardiorespiratory fitness confer some protection against pro- inflammatory responses after infection by SARS- CoV-2? |
| cord-334773-yw2qgv13 | Dipeptidyl peptidase 4 distribution in the human respiratory tract implications for the middle east respiratory syndrome COVID-19 and diabetes: can DPP4 inhibition play a role? |
| cord-334773-yw2qgv13 | Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome? |
| cord-334773-yw2qgv13 | F1000Prime Rep Is there a role for statin therapy in acute viral infections? |
| cord-334773-yw2qgv13 | Functional assessment of cell entry and receptor usage for SARS- CoV-2 and other lineage B betacoronaviruses COVID-19 and comorbidities: a role for dipeptidyl peptidase 4( DPP4) in disease severity? |
| cord-334773-yw2qgv13 | Hollingsworth, How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-334773-yw2qgv13 | Is the ACE2 overexpression a risk factor for COVID-19 infection? |
| cord-334773-yw2qgv13 | Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in Potential effects of coronaviruses on the cardiovascular system: a review Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? |
| cord-334773-yw2qgv13 | Should anti- diabetic medications be reconsidered amid COVID-19 pandemic? |
| cord-334773-yw2qgv13 | Sliding Scale Insulin Use: Myth or Insanity? |
| cord-334773-yw2qgv13 | The etiology of lower respiratory tract infections in people with diabetes Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus( MERS- CoV): a systematic review and meta- analysis Benefits of flu vaccination for persons with diabetes mellitus: a review COVID-19 and diabetes: knowledge in progress Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study Influenza virus and glycemic variability in diabetes: a killer combination? |
| cord-334773-yw2qgv13 | Worse progression of COVID-19 in men: is testosterone a key factor? |
| cord-334773-yw2qgv13 | inhibitors/ angiotensin receptor blockers have a biphasic effect? |
| cord-334773-yw2qgv13 | medRxiv ACE2 in BRain physiology and pathophysiology: evidence from transgenic animal models ACE2 and diabetes: ACE of ACEs? |
| cord-334773-yw2qgv13 | the conundrum Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-007331-wccmeaep | 0.1 to 0.5 mg/ kg 1 M or SC q12 h) is well- tolerated by ferrets?' |
| cord-007331-wccmeaep | 10 catheters can be left in place for several days during which time prophylactic use of parenteral antibiotics is recommended? |
| cord-007331-wccmeaep | 33, 42 Sedation is recommended for cystocentesis in all but very debilitated ferrets, because the bladder wall is thin and can be easily lacerated if the patient struggles? |
| cord-007331-wccmeaep | 42 Whole blood can be transfused immediately with a slow bolus or with a syringe pump?' |
| cord-007331-wccmeaep | A healthy ferret's blood volume is approximately 5% to 6% of its body weight? |
| cord-007331-wccmeaep | A method for obtaining volumes of as much as 1.0 to 1.5 mL of blood from the ventral tail artery of ferrets has been described? |
| cord-007331-wccmeaep | A rectal probe may increase the usefulness of the pulse oximeter in small animals, 35 Clinical signs of pain in ferrets include lethargy, anorexia, vocalization, stiff movements, reluctance to curl up in a sleeping position, and squinting? |
| cord-007331-wccmeaep | Administer IV fluids to debilitated patients, taking care to avoid overhydration, especially in patients suspected of having cardiac disease, Administer 2.5% to 5% dextrose- containing fluids to hypoglycemic ferrets during prolonged surgical procedures?' |
| cord-007331-wccmeaep | Fractious ferrets can be scruffed in lateral or sternal recumbency with one hand while placing the other hand cranial to the pelvis and stretching the body slightly? |
| cord-007331-wccmeaep | Hold the ferret at a table's edge or in lateral recumbency as for a cat, or alternatively, wrap the ferret in a towel and restrain in dorsal recumbency? |
| cord-007331-wccmeaep | If necessary, naloxone( 0.04 mg/ kg IV, 1 M, or SC) can be administered as a reversal agent? |
| cord-007331-wccmeaep | Maintenance fluid requirement for the ferret is estimated at 70 mL/ kg/ 24 h? |
| cord-007331-wccmeaep | Many ferrets hypersalivate during isoflurane induction, but because this is usually a transient behavior, atropine is generally not necessary? |
| cord-007331-wccmeaep | Most cases of urethral obstruction involve male ferrets and are the result of cystic calculi or hyperplastic prostatic- like tissue at the neck of the bladder? |
| cord-007331-wccmeaep | Most medications given intravenously, with the exception of some chemotherapeutic drugs, can alternatively be administered via an 10 catheter? |
| cord-007331-wccmeaep | Pharyngostomy tube placement in ferrets has been described? |
| cord-007331-wccmeaep | The ferret's normal GI transit time is 3 to 4 hours? |
| cord-007331-wccmeaep | There is no evidence that ferrets demonstrate a leukocytosis with stress? |
| cord-007331-wccmeaep | There is no guarantee of stability.51 Transfusion in the ferret has been recommended when the PCV drops below 12% to 15%, depending on whether the anemia is acute or has developed gradually.42 Blood groups have not been demonstrated in ferrets, and there is little risk of a transfusion reaction even without crossmatching and after using a variety of donors?' |
| cord-007331-wccmeaep | Use a small vaginal speculum or otoscope cone to locate the urethral opening on the ventral floor of the vaginal vestivule, approximately 1 to 1.5 cm cranial to the clitoral fossa?' |
| cord-007331-wccmeaep | localities mandate euthanasia of the animal for rabies testing? |
| cord-346539-kxnrf5g5 | -An updated interim review and lessons from SARS- CoV and MERS- CoV Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-346539-kxnrf5g5 | 152 pandemic? |
| cord-346539-kxnrf5g5 | 50,153 endotype is associated with severe asthma in obese patients, are obese asthmatic patients more likely to develop severe COVID-19? |
| cord-346539-kxnrf5g5 | : why might they be hazardous? |
| cord-346539-kxnrf5g5 | Advances in Diagnosis and Treatment BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-346539-kxnrf5g5 | Advice for Healthcare Professionals Treating People with Asthma( adults) in relation to COVID-19 COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids Asthma and COVID-19: is asthma a risk factor for severe outcomes? |
| cord-346539-kxnrf5g5 | Covid-19-Navigating the Uncharted COVID-19, SARS and MERS: are they closely related? |
| cord-346539-kxnrf5g5 | Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS- CoV-2 infection is associated with disease severity and fatal outcome Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-346539-kxnrf5g5 | IgG1(+) B- cell immunity predates IgE responses in epicutaneous sensitization to foods Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown? |
| cord-346539-kxnrf5g5 | Is BCG vaccination affecting the spread and severity of COVID-19? |
| cord-346539-kxnrf5g5 | Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-346539-kxnrf5g5 | The Multifaceted B Cell Response in Allergen Immunotherapy COVID-19 Autopsies EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity Lung eosinophils- A novel"virus sink"that is defective in asthma? |
| cord-346539-kxnrf5g5 | The iceberg of COVID-19: are there asymptomatic cases below the surface? |
| cord-346539-kxnrf5g5 | These zoonotic beta- coronaviruses share structural and genomic similarities that are useful to patients? |
| cord-346539-kxnrf5g5 | Twelve Years after Pathogenesis of Acute Respiratory Distress Syndrome Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives-a report of the 1 COVID-19 pneumonia: ARDS or not? |
| cord-346539-kxnrf5g5 | What specific therapies can be suggested for ARDS? |
| cord-346539-kxnrf5g5 | Which cytokines are most elevated during CSS? |
| cord-346539-kxnrf5g5 | Will helminth co- infection modulate COVID-19 severity in endemic regions? |
| cord-346539-kxnrf5g5 | [ 277][ 278][ 279] What is the evidence supporting social distancing and face mask to prevent SARS- CoV-2 infection? |
| cord-346539-kxnrf5g5 | an urgent public health research priority Is ethnicity linked to incidence or outcomes of covid-19? |
| cord-346539-kxnrf5g5 | pandemic? |
| cord-014687-0am4l5ms | : How Big a Problem is It? |
| cord-014687-0am4l5ms | : Where Are We Now? |
| cord-014687-0am4l5ms | A conversant? |
| cord-014687-0am4l5ms | Been a leader in science and application? |
| cord-014687-0am4l5ms | Been part of the dialogue that has been increasingly influential across all of Radiology, a conversation steeped in a deep tradition of excellence in diagnosis and treatment, and the safety and welfare of our children? |
| cord-014687-0am4l5ms | Can Time- Resolved Contrast- Enhanced MRA( TWIST) Classify Soft Tissue Vascular Anomalies in the Head and Neck in Children Accurately? |
| cord-014687-0am4l5ms | Does a Tertiary Care Radiologist Make a Difference? |
| cord-014687-0am4l5ms | Has he been part of the Pediatric Radiology landscape these last ten years? |
| cord-014687-0am4l5ms | Horizons, innovation, and the gift of en- abling … What else is needed to define a true pioneer? |
| cord-014687-0am4l5ms | How can we maintain and expand these relationships? |
| cord-014687-0am4l5ms | How was this done? |
| cord-014687-0am4l5ms | Imaging Followup of Lymphoma in Pediatric Patients: Is Pelvic CT Necessary? |
| cord-014687-0am4l5ms | Imaging Pulmonary Tuberculosis in Infants: What are the Most Useful Diagnostic Radiological Findings? |
| cord-014687-0am4l5ms | Is Dedicated Chest CT needed in Addition to PET CT for Evaluation of Pediatric Oncology Patients? |
| cord-014687-0am4l5ms | M.D. Why George Bisset? |
| cord-014687-0am4l5ms | Part of the dialogue? |
| cord-014687-0am4l5ms | Part of the landscape? |
| cord-014687-0am4l5ms | Part of the science and application? |
| cord-014687-0am4l5ms | Sonographic Evaluation of Pediatric Skeletal Lesions: Is it worthwhile? |
| cord-014687-0am4l5ms | Utility of Contrast- Enhanced MR Imaging in Children with Osteonecrosis: Does Gadolinium Help? |
| cord-014687-0am4l5ms | With these successes in mind, who better to embody the concept of bridging horizons that is the theme for this entire meeting? |
| cord-279255-v861kk0i | ( COVID-19) outbreak: could pigs be vectors for human infections? |
| cord-279255-v861kk0i | 2019 novel coronavirus( 2019-nCoV): what advice can we give to travellers? |
| cord-279255-v861kk0i | : what have we learned? |
| cord-279255-v861kk0i | : what is the role of radiologists? |
| cord-279255-v861kk0i | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand- related issue? |
| cord-279255-v861kk0i | Can SARS- CoV-2 infection be acquired in utero? |
| cord-279255-v861kk0i | Can cats become infected with Covid-19? |
| cord-279255-v861kk0i | Can companion animals become infected with Covid-19? Leading veterinary diagnostic company |
| cord-279255-v861kk0i | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-279255-v861kk0i | However, the real question is, how are we planning to counter the next zoonotic CoV epidemic that is likely to occur within the next 5 to 10 years or perhaps sooner? |
| cord-279255-v861kk0i | Influenza Other Respir Viruses Does hand hygiene reduce SARS- CoV-2 transmission? |
| cord-279255-v861kk0i | More definitive evidence is needed Wuhan virus: Chinese animal markets reopened with almost no precautions China must close down"wet markets Will they ever learn? |
| cord-279255-v861kk0i | Rational vaccine design in the time of COVID-19 Bacillus Calmette Guérin( BCG) vaccination use in the fight against COVID-19-what's old is new again? |
| cord-279255-v861kk0i | Reply to"Does hand hygiene reduce SARS- CoV-2 transmission? |
| cord-279255-v861kk0i | The establishment of reference sequence for SARS- CoV-2 and variation analysis Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-279255-v861kk0i | The next big threat to global health? |
| cord-279255-v861kk0i | What do we know about the SARS- CoV-2 coronavirus in the environment? |
| cord-279255-v861kk0i | What is the potential impact of the Amazon wildfires on vector- borne and zoonotic emerging diseases? |
| cord-279255-v861kk0i | and now the 2019-novel CoV: have we investigated enough about coronaviruses? |
| cord-279255-v861kk0i | e12591 Infection and rapid transmission of SARS- CoV-2 in ferrets Current therapeutic applications and pharmacokinetic modulations of ivermectin Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment? |
| cord-279255-v861kk0i | is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-279255-v861kk0i | proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China Emerging viruses without borders: the Wuhan coronavirus China coronavirus: what do we know so far? |
| cord-023913-pnjhi8cu | A well- designed EMR system can"stack"required co- signing tasks on a computer screen, offer standard entries as well as free- hand options, and create a process far faster than paper records for an attending's validation( same as reconciliation?). |
| cord-023913-pnjhi8cu | Are these rare variants the source of much of the missing heritability? |
| cord-023913-pnjhi8cu | Basic sciences aside, could a clinicalbased educational training center have an advantage over a school- based clinical center? |
| cord-023913-pnjhi8cu | Dental care for your baby Does caries in primary teeth predict enamel defects in permanent teeth? |
| cord-023913-pnjhi8cu | For those affected, why do some progress more rapidly than others? |
| cord-023913-pnjhi8cu | He also posed the question"Can dentists recognize signs and systems of contagious diseases?", and emphasized that education can be essential. |
| cord-023913-pnjhi8cu | How does one measure the economic impact of a life not lived and another derailed by such tragedy? |
| cord-023913-pnjhi8cu | How much would all of this cost? |
| cord-023913-pnjhi8cu | How will we seize them? |
| cord-023913-pnjhi8cu | How would it compare to the benefi ts that may be available? |
| cord-023913-pnjhi8cu | Is it better to travel down a road that leads a school to develop and operate a clinic? |
| cord-023913-pnjhi8cu | Might an enterprise profi cient at running a successful clinical business model have an advantage running a professional, patient- centered clinical training program as compared to a pedagogical business model attempting to run a clinical training model? |
| cord-023913-pnjhi8cu | Need we say more? |
| cord-023913-pnjhi8cu | Or is the road less traveled, where a clinic becomes a school, the better of the two options? |
| cord-023913-pnjhi8cu | Oral Surg Oral Med Oral Pathol Oral Radiol Endod Oral hygiene can reduce the incidence of and death resulting from pneumonia and respiratory tract infection Effect of daily asprin on long- term risk of death due to cancer: analysis of individual patient data from randomized trails Access to oral health care for elders: mere words or action? |
| cord-023913-pnjhi8cu | So what do we mean by an aggressive dental treatment plan? |
| cord-023913-pnjhi8cu | The evolution of molecular markers-just a matter of fashion? |
| cord-023913-pnjhi8cu | The relationship between reduction in periodontal infl ammation and diabetes control: a report of 9 cases Can presence or absence of periodontal pathogens distinguish between subjects with chronic and aggressive periodontitis? |
| cord-023913-pnjhi8cu | To what extent are medical and dental and providers aware of recommendations for a fi rst dental visit for a child by age one, as recommended by the AAP, the American Academy of Pediatric Dentistry( AAPD), and the American Dental Association? |
| cord-023913-pnjhi8cu | What about cardiovascular disease and rheumatoid arthritis? |
| cord-023913-pnjhi8cu | What causes some patients to respond to therapies, while others suffer from adverse reactions? |
| cord-023913-pnjhi8cu | What's strange about recent events? |
| cord-023913-pnjhi8cu | Why do some acquire diseases and others do not? |
| cord-023913-pnjhi8cu | what value, what price? |
| cord-022467-j2trahab | : what does it mean? |
| cord-022467-j2trahab | : what is the role of expired nitric oxide measurement? |
| cord-022467-j2trahab | A controlled trial of traditional Chinese medicinal plants in widespread non- exudative atopic eczema One- year follow up of children treated with Chinese medicinal herbs for atopic eczema Childhood immunizations: controversy and change Therapeutic orphans Vaccination and autoimmunity-"vaccinosis": a dangerous liaison? |
| cord-022467-j2trahab | A dose- response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold Are patients who use alternative medicine dissatisfied with orthodox medicine? |
| cord-022467-j2trahab | A double- blind crossover study Ten- year stability of EEG biofeedback results for a hyperactive boy who failed fourth grade perceptually impaired class Randomised trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series Autism, inflammatory bowel disease, and MMR vaccine Is measles vaccination a risk factor for inflammatory bowel disease Acupuncture treatment for aerotitis media Herbal medicines for children: an illusion of safety? |
| cord-022467-j2trahab | A longitudinal comparison of irritable and nonirritable infants Use of unconventional therapies by children with cancer at an urban medical center Role of leukotriene receptor antagonists in pediatric asthma Consultations for holistic pediatric services for inpatients and outpatient oncology patients at a children's hospital Holistic pediatrics: a research agenda On pins and needles? |
| cord-022467-j2trahab | An approach to pediatric upper respiratory infections Infantile colic: is it a gut issue? |
| cord-022467-j2trahab | Changing prevalence of allergic rhinitis and asthma Over- the- counter cold medications: a critical review of clinical trials between 1950 and Prevention of allergic disorders Alternative medicine: should it be used by children? |
| cord-022467-j2trahab | Chiropractic management of primary nocturnal enuresis Is homeopathy a placebo response? |
| cord-022467-j2trahab | Homeopathic treatment of childhood diarrhea Alternative therapies commonly used within a population of patients with psoriasis Are measles infections or measles immunizations linked to autism? |
| cord-022467-j2trahab | I. Diagnosis and management Attitudes on immunization: a survey of American chiropractors Hypnotherapy in the management of nocturnal enuresis Which asthmatic patients should be treated by hypnotherapy? |
| cord-022467-j2trahab | IgE and eosinophil analyses Traditional Chinese medicines as immunosuppressive agents EEG biofeedback treatment of ADD: a viable alternative to traditional medical intervention? |
| cord-022467-j2trahab | Informed consent in medical research: children from the age of 5 should be presumed competent Satisfaction among patients of a homeopathic clinic Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge? |
| cord-022467-j2trahab | Is autism a G- alpha protein defect reversible with natural vitamin A? |
| cord-022467-j2trahab | Methylphenidate and cognitive therapy: a comparison of treatment approaches with hyperactive boys Alternative treatments for attention- deficit/ hyperactivity disorder: does evidence support their use? |
| cord-022467-j2trahab | Microbiology of bacterial respiratory infections Homeopathic diarrhea trial Bupropion in children with attention deficit disorder Practical approaches to the treatment of atopic dermatitis Forty- seven cases of acne treated by prick- bloodletting plus cupping Two hundred and seventeen cases of winter diseases treated with acupoint stimulation in summer Vaccine adverse events: causal or coincidental? |
| cord-022467-j2trahab | Relationship between breast- feeding duration and acute respiratory infections in infants Cognitive training in ADHD children: less to it than meets the eye Hyperactive children treated with stimulants: is cognitive training a useful adjunct? |
| cord-022467-j2trahab | Serous otitis media( SOM): a bacteriological study of the ear canal and the middle ear Attention- deficit hyperactivity disorder: alternatives for psychotherapy? |
| cord-022467-j2trahab | The child's perception of the human energy field using therapeutic touch Homeopathy in acute otitis media in children: treatment effect or spontaneous resolution? |
| cord-022467-j2trahab | The effects of nasal massage of the"yingxiang"acupuncture point on nasal airway resistance and sensation of nasal airflow in patients with nasal congestion associated with acute upper respiratory tract infection Treatment of fever due to exopathic wind- cold by rapid acupuncture Attention deficit hyperactivity disorder: pharmacotherapy and beyond Acupuncture for bronchial asthma? |
| cord-022467-j2trahab | The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections Does breast feeding protect against non- gastric infections? |
| cord-022467-j2trahab | The influence of acupuncture on interleukin 2-interferon: natural killer cell regulatory network of kidney- deficiency mice Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold? |
| cord-022467-j2trahab | The role of viral and atypical bacterial pathogens in asthma pathogenesis Immunomodulatory effects of acupuncture in the treatment of allergic asthma: a randomized controlled study and otalgia: benign common cold or dangerous infection? |
| cord-022467-j2trahab | The use of self- hypnosis in the treatment of childhood nocturnal enuresis: a report on forty patients Hypnotherapy in children: new approach to solving common pediatric problems Hypnosis and hypnotherapy with children Validation of an index of the quality of review articles Home- based therapies for the common cold among European American and ethnic minority families: the interface between alternative/ complementary and folk medicine Development of secretory elements in murine tubotympanum: lysozyme and lactoferrin immunohistochemistry Crohn's disease, and autism: a real or imagined"stomachache/ headache? |
| cord-022467-j2trahab | The usefulness of a minimal urodynamic evaluation and pelvic floor biofeedback in children with chronic voiding dysfunction Acupressure: a point of pressure Group A beta- hemolytic streptococcal infections Therapy for acute infectious diarrhea in children Strategies for consoling the infant with colic: fact or fiction? |
| cord-022467-j2trahab | Why do patients turn to complementary medicine? |
| cord-022467-j2trahab | Worldwide variations in the prevalence of atopic symptoms: what does it all mean? |
| cord-009664-kb9fnbgy | ( Symposium arranged with EFWISG) S460 MRSA in food products: cause for concern or case for complacency? |
| cord-009664-kb9fnbgy | And are we gaining or losing? |
| cord-009664-kb9fnbgy | And the equally valid question: to what extent does biological science benefit from study of fungi that are opportunistic pathogens? |
| cord-009664-kb9fnbgy | Are we aware? |
| cord-009664-kb9fnbgy | Are we in command? |
| cord-009664-kb9fnbgy | Clinical microbiology − is outsourcing the way to go? |
| cord-009664-kb9fnbgy | Do the efflux pump inhibitors reserpine and verapamil reduce the mutation frequency? |
| cord-009664-kb9fnbgy | Do we have a choice? |
| cord-009664-kb9fnbgy | Do we know where we are going? |
| cord-009664-kb9fnbgy | Do we recognise a driving force other than money? |
| cord-009664-kb9fnbgy | Does efflux phenotype impose a fitness cost? |
| cord-009664-kb9fnbgy | Emerging infections: can we cope with them? |
| cord-009664-kb9fnbgy | Furthermore, is there a pathophysiological impact of viral replication in individuals with CIHHV-6? |
| cord-009664-kb9fnbgy | If you do n't look for them, you wo n't find them: anaerobes revisited S481 Anaerobic microbiota of the mouth − friend or foe? |
| cord-009664-kb9fnbgy | Is it good, bad or just plain necessary? |
| cord-009664-kb9fnbgy | MRSA screening − will we ever agree? |
| cord-009664-kb9fnbgy | O391 Throwing caution to the winds? |
| cord-009664-kb9fnbgy | PBP 3 − SOS response? |
| cord-009664-kb9fnbgy | Patient management: the era of rapid diagnostic results( Symposium organised by Cepheid) S161 Will community MRSA and Clostridium difficile change infection control in hospitals? |
| cord-009664-kb9fnbgy | S485 Is culture still the gold standard, really? |
| cord-009664-kb9fnbgy | Should we oppose or cooperate? |
| cord-009664-kb9fnbgy | So, it is unclear how the transcription and translation of viral genes is influenced? |
| cord-009664-kb9fnbgy | The( r)evolution of clinical microbiology in Europe − is it good or bad? |
| cord-009664-kb9fnbgy | To what extent do patients benefit from translation of basic research into tools for clinical management? |
| cord-009664-kb9fnbgy | What about Europe? |
| cord-009664-kb9fnbgy | What is driving the evolution? |
| cord-009664-kb9fnbgy | or gyrA QRDR mutation frequencies than efflux negative isolates? |
| cord-009664-kb9fnbgy | which antifungal treatment for which patient? |
| cord-315598-qwh72inx | A Missing Link? |
| cord-315598-qwh72inx | Ann Intensive Care Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta- analysis Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis- Associated Organ Dysfunction in Children Use of ECMO in ARDS: does the EOLIA trial really help? |
| cord-315598-qwh72inx | COVID-19 pneumonia: ARDS or not? |
| cord-315598-qwh72inx | COVID-19 pneumonia: different respiratory treatment for different phenotypes? |
| cord-315598-qwh72inx | Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus( COVID-19) Pneumonia? |
| cord-315598-qwh72inx | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
| cord-315598-qwh72inx | Cómo podemos medir la calidad de vida, en los pacientes con COVID-19 que egresan de la uci? |
| cord-315598-qwh72inx | Documento de Rionegro Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019( COVID-19) COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-315598-qwh72inx | Does COVID19 Infect the Brain? |
| cord-315598-qwh72inx | Does SARS- Cov-2 invade the brain? |
| cord-315598-qwh72inx | Does central venous pressure predict fluid responsiveness? |
| cord-315598-qwh72inx | Heart Lung Patient selfproning with high- flow nasal cannula improves oxygenation in COVID-19 pneumonia Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience Sedation for critically ill patients with COVID-19: Which specificities? |
| cord-315598-qwh72inx | How should health systems prepare for the evolving COVID-19 pandemic? |
| cord-315598-qwh72inx | How will countrybased mitigation measures influence the course of the COVID-19 epidemic? |
| cord-315598-qwh72inx | Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome Driving pressure and survival in the acute respiratory distress syndrome Driving pressure: a marker of severity, a safety limit, or a goal for mechanical ventilation? |
| cord-315598-qwh72inx | Management of COVID-19 Respiratory Distress Stages or phenotypes? |
| cord-315598-qwh72inx | Noninvasive ventilation in acute cardiogenic pulmonary edema Noninvasive Ventilation in Acute Heart Failure Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure Is there a role for noninvasive ventilation in acute respiratory distress syndrome? |
| cord-315598-qwh72inx | Pautas COVID-19 HiSpaFlow) endGEMdTdScAFeA. Respiratory support therapy after extubation: Who and how? |
| cord-315598-qwh72inx | Pdlr An international survey of training in adult intensive care medicine Do intensivist staffing patterns influence hospital mortality following ICU admission? |
| cord-315598-qwh72inx | Por qué seguimos buscando métodos alternativos? |
| cord-315598-qwh72inx | Radiography( Lond) Point- of- Care Lung Ultrasound Findings in Patients with COVID-19 Pneumonia Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic D- dimer in patients infected with COVID-19 and suspected pulmonary embolism Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Anticoagulation in COVID-19 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta- analysis Procalcitonin in patients with severe coronavirus disease 2019( COVID-19): A meta- analysis Viral load of SARS- CoV-2 in clinical samples Discharge criteria for confirmed COVID-19 cases-When is it safe to discharge COVID-19 cases from the hospital or end home isolation? |
| cord-315598-qwh72inx | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-315598-qwh72inx | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-315598-qwh72inx | What are the effects of multimodal campaigns to improve hand hygiene of healthcare workers? |
| cord-315598-qwh72inx | Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids? |
| cord-315598-qwh72inx | a la bata manga larga con antifluido durante la atención del paciente con COVID-19? |
| cord-315598-qwh72inx | beneficios en desenlaces clínicos de interés? |
| cord-315598-qwh72inx | convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-315598-qwh72inx | de COVID-19? |
| cord-315598-qwh72inx | why, when and how? |
| cord-001221-due9tloa | 1) Is this a true occlusion( how to differentiate it from adynamic ileus)? |
| cord-001221-due9tloa | 2) Does the obstruction concern the small bowel or the colon( impacting on the decision to operate or not)? |
| cord-001221-due9tloa | 4) Are there signs of bowel ischaemia? |
| cord-001221-due9tloa | A-017 17:00 C. MR/ PET: do we really need it? |
| cord-001221-due9tloa | And if so, which kinds of images( CT, MRI, x- ray, etc).? |
| cord-001221-due9tloa | Are there associated findings other than GGO, such as nodules, reticulation or focal disease, and distribution of findings that can narrow the differential diagnosis? |
| cord-001221-due9tloa | Are there specific radiological and HRCT findings that can help us differentiate GGO in autoimmune inflammatory conditions from infectious and neoplastic processes? |
| cord-001221-due9tloa | Are there sufficient data to support the implementation of individual lung cancer screening in clinical practice? |
| cord-001221-due9tloa | Cardiac MR/ PET: Do we really need it? |
| cord-001221-due9tloa | How accurate and prognostically valid is coronary CT angiography? |
| cord-001221-due9tloa | How can we manage the portability of patients'data( security issues, data loss, etc).? |
| cord-001221-due9tloa | How can we reduce the amount of contrast agent by volume? |
| cord-001221-due9tloa | How can we reduce the amount of iodine concentration in the contrast agent? |
| cord-001221-due9tloa | How can we reduce the time of cardiac CT studies? |
| cord-001221-due9tloa | How can we reduce the x- ray dose? |
| cord-001221-due9tloa | How should subjects be informed about screening? |
| cord-001221-due9tloa | In view of this rapid technological development, again radiology falls in the middle of a storm and is asked to find a solution to problem: are tablets suitable to read and report DICOM images? |
| cord-001221-due9tloa | Is cell imaging relevant for the clinic? |
| cord-001221-due9tloa | Key components of differential diagnosis is configuration of the enhancement( does it follow the orientation of the milk duct or not?) |
| cord-001221-due9tloa | Right heart and chronic respiratory diseases: can CT be used as a onestop- shop? |
| cord-001221-due9tloa | Stereotactic radiofrequency ablation of liver tumours: does improved targeting increase tumour response? |
| cord-001221-due9tloa | Therefore, what happens in those patients in whom we found highly suggestive lesions but have never had symptoms? |
| cord-001221-due9tloa | What about the alternatives of waiting for additional data from ongoing trials or the validation of new biomarkers of lung cancer, permitting better selection of screened population before implementing individual lung cancer screening? |
| cord-001221-due9tloa | What are the most optimised risk profiles for screening? |
| cord-001221-due9tloa | What are the optimal follow- up duration and screening interval? |
| cord-001221-due9tloa | What are the protocols with the lowest radiation dose in clinical practice? J.-F. |
| cord-001221-due9tloa | What are the technical and positive screen management requirements? |
| cord-001221-due9tloa | What is the cause of the obstruction? |
| cord-001221-due9tloa | What is the minimum level of infrastructure support and organisation required? |
| cord-001221-due9tloa | What is the radiographer's role in cardiac CT studies? |
| cord-001221-due9tloa | What will be the impact on teleradiology? |
| cord-001221-due9tloa | Where are the turf battles in diagnostic imaging? |
| cord-001221-due9tloa | Why is it important in your imaging protocol of the IAC and CPA region to use gadolinium? |
| cord-001221-due9tloa | how? |
| cord-010980-sizuef1v | ( 2) Are direct oral anticoagulants( DOACs) associated with better survival than vitamin K antagonists( VKA) in TBI patients on anticoagulation? |
| cord-010980-sizuef1v | ( A2? |
| cord-010980-sizuef1v | ( F1? 2). |
| cord-010980-sizuef1v | 1 Los Angeles County? |
| cord-010980-sizuef1v | : Do they speak the same language? |
| cord-010980-sizuef1v | : The 40 patients of the 2018 pilot study''Trauma and Coagulation''run in IRCCS San Raffaele Scientific Institute have been reviewed and analyzed using a suite of experimental coagulation factors including ROTEM parameters, activated protein C( aPC), thrombomodulin, endothelial protein C receptor, thrombin- antithrombin complex( TAT), plasminogen activator inhibitor 1( PAI-1), sESelectin, interleukin-8( IL-8), interleukin-10( IL-10), D- dimer( XDP), antithrombin III( ATIII), and prothrombin fragment F1? |
| cord-010980-sizuef1v | A serosa injury was made on the small intestine and three different treatments were applied: simple suture, simple suture? OxiplexAP, and Oxiplex- AP only; the last group received no treatment of the injury before closure of the abdomen. |
| cord-010980-sizuef1v | At second look laparotomy a significant difference in adhesion was noticed between the simple sutures and simple suture? |
| cord-010980-sizuef1v | BMI( p= 0,043), type of osteosynthesis( p= 0,024), DHS? |
| cord-010980-sizuef1v | But is this really necessary? |
| cord-010980-sizuef1v | Can vascular injury be appropriately assessed with physical examination after knee dislocation? |
| cord-010980-sizuef1v | Can we expect an optimum result? |
| cord-010980-sizuef1v | Clinical findings: Patient had a diffusedlty tender abdomen and had not passed flatus proceeding his admission to the A? |
| cord-010980-sizuef1v | Critical surgery within the first hour of presentation: is it a feasible intervention for better trauma care outcomes in Low and Middle income countries? |
| cord-010980-sizuef1v | Did ultrasound fulfill the promise of safety in regional anesthesia? |
| cord-010980-sizuef1v | Does Garden''s classification of femoral neck fracture match between orthopedic specialist and clinical resident? |
| cord-010980-sizuef1v | Does the number of a- or low symptomatic but intervention requiring complications justify regularly chest X- ray controls after less than 3 rib fractures? |
| cord-010980-sizuef1v | How accurate can gaps and step- offs be determined in acetabular fracture treatment? |
| cord-010980-sizuef1v | However, it still should be considered as a cause of A? |
| cord-010980-sizuef1v | I injuries? |
| cord-010980-sizuef1v | In 2( 2.4%) patients, the SCS[ MCS? 2 mm. |
| cord-010980-sizuef1v | Intensities of GABA, glutamate? |
| cord-010980-sizuef1v | Is operative therapy still warranted for dislocated acetabular fractures in elderly patients? |
| cord-010980-sizuef1v | Material and Methods: 365 operations were performed for trochanteric fracture( AO 31A1? A2) from 2012 to 2018. |
| cord-010980-sizuef1v | Materials and methods: We used a qualitative design and included older patients( 65? years) with a variety of( severe) injuries, who were admitted to the emergency department after an e- bike accident( n= 12) and their relatives( n= 11). |
| cord-010980-sizuef1v | Mean MCS on mortise radiograph was 3.3 mm( range 1.7- 5.9); in 12( 13.3%) patients the MCS was[ 4 mm and in 15 patients( 18.3%) the superior clear space( SCS) was[ MCS? 1 mm. |
| cord-010980-sizuef1v | Mediastinum widening: how to manage it? |
| cord-010980-sizuef1v | Missed ureteric injuries in gunshot injuries of the abdomen: how to avoid? |
| cord-010980-sizuef1v | Open Orthop J. 2012;6:531- 4 Is ultrasound- guided regional anesthesia safer than landmark technique? |
| cord-010980-sizuef1v | Rib fractures associated with pneumo- and/ or hemothorax; does everyone need a chest tube? |
| cord-010980-sizuef1v | She attended A? |
| cord-010980-sizuef1v | Splenectomy in current surgical practice: a tricky and elusive procedure for the surgical resident? |
| cord-010980-sizuef1v | Symptom triggered reappearance for patients after rib fractures in hospitals seems to be sufficient and more economical compared to regularly re- imaging( 2) Is computed tomography a first line modality in stable blunt chest trauma elderly patients? |
| cord-010980-sizuef1v | The association between trauma patient characteristics and adverse laboratory values: which patient characteristics are most predictive? |
| cord-010980-sizuef1v | The need for extraperitonal pelvic packing-finally confirmed to be vanishing? |
| cord-010980-sizuef1v | Therapy and Progressions: Patient was taken to theatre for laparoscopy? |
| cord-010980-sizuef1v | There are two research questions addressed in this study:( 1) Does preinjury antithrombotic therapy affect survival in elderly patients with TBI? |
| cord-010980-sizuef1v | This increase depends on the Zone of inflation( increase of? |
| cord-010980-sizuef1v | case series review and discussion Trauma patients with open abdomen: do they differ from others? |
| cord-000843-e1bn79ui | ( 1) Is there a lesion in the brain? |
| cord-000843-e1bn79ui | ( 2) Is the lesion a tumour? |
| cord-000843-e1bn79ui | ( 3) Is the tumour a glioma? |
| cord-000843-e1bn79ui | ( 4) Is it a high- or low- grade glioma? |
| cord-000843-e1bn79ui | ( 8) After radiotherapy, if a new enhancing lesion occurs, is it a recurrent neoplasm or radiation necrosis? |
| cord-000843-e1bn79ui | Are they always important, do they perhaps predict the development of more severe disease, or are there cases where they have little influence on diagnosis and therapy? |
| cord-000843-e1bn79ui | Behaving ethically towards one's own profession, towards the others and towards ourselves, is it, or could this be the common ground of European professional ethics? |
| cord-000843-e1bn79ui | Can CT predict the outcome of percutaneous intervention? |
| cord-000843-e1bn79ui | Can we assess cell density of tumours with imaging techniques? |
| cord-000843-e1bn79ui | Can we predict the athletes return to sport? |
| cord-000843-e1bn79ui | Can we still use the term BME or should we be more specific? |
| cord-000843-e1bn79ui | Could the'molecule of life'also be the'molecule of the mind'? |
| cord-000843-e1bn79ui | Facts from the statistician( true for once?) |
| cord-000843-e1bn79ui | How can imaging techniques discriminate recurrence, inflammation, necrosis or scar? |
| cord-000843-e1bn79ui | How do we report CT of the chest? |
| cord-000843-e1bn79ui | How to design such algorithms? |
| cord-000843-e1bn79ui | However, the clinically important question should rather be the following: Does this higher accuracy have an impact on patient management? |
| cord-000843-e1bn79ui | If there is need for adjunctive radiotherapy, how the extent of the tumour should be defined? |
| cord-000843-e1bn79ui | Imaging of adnexal masses: is it feasible to diagnose ovarian cancer? |
| cord-000843-e1bn79ui | In this setting, and mindful of the medico legal consequences of'delayed diagnosis', is there still room to allow a patient to leave the one stop clinic without a definitive diagnosis? |
| cord-000843-e1bn79ui | Is it now feasible in daily practice? |
| cord-000843-e1bn79ui | Is it time for integrating standard imaging with the functional information provided by DWI and/or CT or MR perfusion techniques? |
| cord-000843-e1bn79ui | Is mammography still an accepted modality for breast cancer imaging in 2025? |
| cord-000843-e1bn79ui | Is the lesion cystic or solid? |
| cord-000843-e1bn79ui | Is there any risk of the radiologist having a detrimental impact on either the welfare of the patient or the judicial process by either under- diagnosing or over- diagnosing child abuse? |
| cord-000843-e1bn79ui | Stroke around the clock: will the challenger( CT perfusion) beat the champion( diffusion MRI)? |
| cord-000843-e1bn79ui | The question becomes: are these techniques ready for routine clinical use or are they most appropriate for research? |
| cord-000843-e1bn79ui | We will conclude with a panel discussion asking the question: are the repeatability, reproducibility, and robustness of the non- invasive biomarkers presented in this session adequate for routine clinical implementation? |
| cord-000843-e1bn79ui | What have we learned from our mistakes? 09:44 |
| cord-000843-e1bn79ui | What is the role of MR( as well as MRS, DW MR and dynamic MR) in precluding the need for multiple biopsies? |
| cord-000843-e1bn79ui | What specific precautions are mandatory in order to guarantee contrast media safety to patients and healthcare professionals? |
| cord-000843-e1bn79ui | What will be the standard machine and field of the future? |
| cord-000843-e1bn79ui | What would happen if our professional identity were perceived and acknowledged through the way we can interact and relate to others? |
| cord-000843-e1bn79ui | When do we need"neuroimaging"and what is the optimal diagnostic work- up? |
| cord-000843-e1bn79ui | When should an expiratory scan be performed? |
| cord-000843-e1bn79ui | When should we report these changes? |
| cord-000843-e1bn79ui | When should we stop in cases with high or increasing levels of PSA despite consecutive negative biopsy outcomes? |
| cord-000843-e1bn79ui | Where do we stand in brain aneurysm treatment today? |
| cord-000843-e1bn79ui | Where do we stand in stroke therapy today? |
| cord-000843-e1bn79ui | Where is the mass located? |
| cord-000843-e1bn79ui | Which evidence level are we at presently? |
| cord-000843-e1bn79ui | Which imaging modality is best for endovascular management? |
| cord-000843-e1bn79ui | Why does the radiologist need to understand the importance of monitoring response and how it is done? |
| cord-000843-e1bn79ui | Will new MR contrast probes compete with PET? |
| cord-000843-e1bn79ui | Will new technologies allow a jump in sensitivity? |
| cord-000843-e1bn79ui | Will these technologies allow a jump in sensitivity? |
| cord-000843-e1bn79ui | but when and why do they really matter? |
| cord-026031-hnf5vayd | Any cleaning products used inside or outside the house within the last 48 hours? |
| cord-026031-hnf5vayd | Any construction work or renovation recently? |
| cord-026031-hnf5vayd | Any fertilizers or weed killer used in the last week? |
| cord-026031-hnf5vayd | Any mouse or rat poison in your house, yard, or garage? |
| cord-026031-hnf5vayd | Are there any abnormal postures? |
| cord-026031-hnf5vayd | Are there any characteristic odors on the breath? |
| cord-026031-hnf5vayd | Are there any other abnormal signs that you have seen? |
| cord-026031-hnf5vayd | Are there any pulse deficits or dysrhythmias auscultated? |
| cord-026031-hnf5vayd | Are there any traces of foreign material on the tongue or in the crevices of the teeth or gums? |
| cord-026031-hnf5vayd | Are there petechiae or ecchymosis on the gums or bleeding from the gumline? |
| cord-026031-hnf5vayd | Did the owner attempt any irrigation or medical techniques prior to presentation? |
| cord-026031-hnf5vayd | Did you give any medications to your animal? |
| cord-026031-hnf5vayd | Did you witness the ingestion or exposure? |
| cord-026031-hnf5vayd | Did your pet eat this morning or last night? |
| cord-026031-hnf5vayd | Do the intestinal loops feel normal, or are they fluid- filled or gas- filled? |
| cord-026031-hnf5vayd | Do you have any over- the- counter or prescription medications that your animal may have had access to? |
| cord-026031-hnf5vayd | Do you have the container with you today? |
| cord-026031-hnf5vayd | Do you hear harsh airway sounds or pulmonary crackles? |
| cord-026031-hnf5vayd | Do you observe any ptyalism or attempts to vomit? |
| cord-026031-hnf5vayd | Do you think that the signs have been the same, better, or getting worse? |
| cord-026031-hnf5vayd | Does it appear lethargic or hyperactive? |
| cord-026031-hnf5vayd | Does the animal have access to any poisonous substances? |
| cord-026031-hnf5vayd | Does your animal have access to any known toxins, or does he or she run loose unattended? |
| cord-026031-hnf5vayd | Does your animal have any ongoing or past medical problems? |
| cord-026031-hnf5vayd | Does your animal run loose outdoors unattended? |
| cord-026031-hnf5vayd | Does your pet have access to a compost pile? |
| cord-026031-hnf5vayd | Does your pet have access to neighboring properties( even for a short time)? |
| cord-026031-hnf5vayd | Does your pet run loose unattended? |
| cord-026031-hnf5vayd | For example, is the patient retaining bicarbonate( metabolic alkalosis) because of carbon dioxide retention( respiratory acidosis)? |
| cord-026031-hnf5vayd | Has it changed at all since the owner noticed the problem? |
| cord-026031-hnf5vayd | Has there been any gardening work recently? |
| cord-026031-hnf5vayd | Has there been any prior incident of ocular disease? |
| cord-026031-hnf5vayd | Has your animal been on any medications recently or currently? |
| cord-026031-hnf5vayd | Has your animal been vaccinated recently? |
| cord-026031-hnf5vayd | Has your animal had any previous or similar episodes? |
| cord-026031-hnf5vayd | Has your pet been off your property in the last 24- 48 hours? |
| cord-026031-hnf5vayd | Has your pet been to rural areas in the last week? |
| cord-026031-hnf5vayd | Has your pet had any antiflea/ tick medication within the last week?Your pet's environment Is your animal kept inside or outside of the house? |
| cord-026031-hnf5vayd | Has your pet traveled outside of your immediate geographic location? |
| cord-026031-hnf5vayd | Have any known relatives of your animal had any bleeding disorders? |
| cord-026031-hnf5vayd | Have similar signs occurred in the past? |
| cord-026031-hnf5vayd | Have the signs become better or worse since you first saw them? |
| cord-026031-hnf5vayd | Have you changed your radiator fluid or does a car leak antifreeze? |
| cord-026031-hnf5vayd | Have you fed table scraps or anything new recently? |
| cord-026031-hnf5vayd | How fast did the clinical signs develop? |
| cord-026031-hnf5vayd | How is the patient acting? |
| cord-026031-hnf5vayd | How long ago do you think that your pet was exposed to the poison? |
| cord-026031-hnf5vayd | How long ago was the exposure? |
| cord-026031-hnf5vayd | How long has the animal been acting that way? |
| cord-026031-hnf5vayd | How much did the animal consume? |
| cord-026031-hnf5vayd | How soon did other signs develop? |
| cord-026031-hnf5vayd | If so, what? |
| cord-026031-hnf5vayd | If so, when and how much did your animal consume? |
| cord-026031-hnf5vayd | If so, when? |
| cord-026031-hnf5vayd | If so, which? |
| cord-026031-hnf5vayd | Is abdominal palpation painful? |
| cord-026031-hnf5vayd | Is it a liquid concentrate, dilute spray, or solid? |
| cord-026031-hnf5vayd | Is it fast, normal, or slow? |
| cord-026031-hnf5vayd | Is it moist, dry, bubbling, or frothy, or caked with dirt? |
| cord-026031-hnf5vayd | Is it normal and pink, or dark red( injected), pale, or icteric? |
| cord-026031-hnf5vayd | Is it normal, fast, shallow, or labored? |
| cord-026031-hnf5vayd | Is it synchronous with the heart rate, or are there dropped pulses? |
| cord-026031-hnf5vayd | Is the animal ambulatory, and if so, do you observe any gait abnormalities? |
| cord-026031-hnf5vayd | Is the lens clear and is it in the normal position? |
| cord-026031-hnf5vayd | Is the ocular examination normal? |
| cord-026031-hnf5vayd | Is the pulse bounding, normal, thready, or not palpable? |
| cord-026031-hnf5vayd | Is there a P wave for every QRS, and a QRS for every P wave? |
| cord-026031-hnf5vayd | Is there a chance that your pet may have gotten into the garbage? |
| cord-026031-hnf5vayd | Is there a palpable urinary bladder? |
| cord-026031-hnf5vayd | Is there any history of trauma or known chemical irritant or exposure? |
| cord-026031-hnf5vayd | Is there any possibility of any toxin exposure? |
| cord-026031-hnf5vayd | Is there any possibility of trauma? |
| cord-026031-hnf5vayd | Is there any vomiting, diarrhea, trembling, or seizures? |
| cord-026031-hnf5vayd | Is there evidence of vomiting or diarrhea? |
| cord-026031-hnf5vayd | Is there excessive salivation? |
| cord-026031-hnf5vayd | Is there respiratory distress? |
| cord-026031-hnf5vayd | Is there urine production? |
| cord-026031-hnf5vayd | Is your animal able to walk? |
| cord-026031-hnf5vayd | Is your animal breathing or does it have respiratory difficulty? |
| cord-026031-hnf5vayd | Is your pet kept in a fenced- in yard or allowed to run loose unattended? |
| cord-026031-hnf5vayd | It is useful to phrase questions in a neutral fashion- for example,"Is such- and- such present on the premises?" |
| cord-026031-hnf5vayd | Was the substance swallowed, or is it on the animal's skin or eyes? |
| cord-026031-hnf5vayd | What clinical signs developed? |
| cord-026031-hnf5vayd | What do you hear on thoracic auscultation? |
| cord-026031-hnf5vayd | What is the animal's activity level? |
| cord-026031-hnf5vayd | What is the capillary refill time? |
| cord-026031-hnf5vayd | What is the color and consistency of the feces? |
| cord-026031-hnf5vayd | What is the color of the gums or tongue? |
| cord-026031-hnf5vayd | What is the color of the urine? |
| cord-026031-hnf5vayd | What is the mucous membrane color? |
| cord-026031-hnf5vayd | What is the name of the product? |
| cord-026031-hnf5vayd | What is the nature of the bleeding? |
| cord-026031-hnf5vayd | What is the patient's blood pressure? |
| cord-026031-hnf5vayd | What is the patient's electrocardiogram? |
| cord-026031-hnf5vayd | What is the patient's heart rate? |
| cord-026031-hnf5vayd | What is the patient's rectal temperature? |
| cord-026031-hnf5vayd | What is the patient's respiratory character? |
| cord-026031-hnf5vayd | What is the patient's respiratory rate? |
| cord-026031-hnf5vayd | What is the pupil reactivity to light? |
| cord-026031-hnf5vayd | What is the pupil size? |
| cord-026031-hnf5vayd | What is the quality of the femoral pulse? |
| cord-026031-hnf5vayd | What is the sensitivity to light or sound? |
| cord-026031-hnf5vayd | What is the substance that your animal ingested( was exposed to)? |
| cord-026031-hnf5vayd | What is your chief complaint or reason that you brought your animal in on emergency? |
| cord-026031-hnf5vayd | What other conditions have developed and what are they? |
| cord-026031-hnf5vayd | What sites are affected? |
| cord-026031-hnf5vayd | What was the first abnormal sign noticed? |
| cord-026031-hnf5vayd | When did the signs first start, or when was your animal last normal? |
| cord-026031-hnf5vayd | When did you first notice that something was wrong with your pet? |
| cord-026031-hnf5vayd | When was the animal last seen as normal? |
| cord-026031-hnf5vayd | When was the last time you noticed your pet act normally? |
| cord-026031-hnf5vayd | When was the onset of clinical signs? |
| cord-026031-hnf5vayd | When was the problem first noticed? |
| cord-026031-hnf5vayd | Where do you think it happened? |
| cord-026031-hnf5vayd | Where has your pet been in the last 24 hours? |
| cord-026031-hnf5vayd | if so, where? |
| cord-026031-hnf5vayd | or When was the last time you saw your animal act normally? |
| cord-026031-hnf5vayd | rather than"Could the dog have eaten such- and- such?" |
| cord-026031-hnf5vayd | she normally fed? |
| cord-026031-hnf5vayd | • How long has the bleeding been going on? |